data = [
    {
        "correctAnswerIndex": 2,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>15-20%</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p>This question describes the Rutgeert score for the assessment of\nrecurrence of Crohn's disease at the ileocolonic\nanastomosis.</p>\n\n<p>Despite a large number of endoscopic scoring systems available,\nfew have been validated to be of clinical use. However, the\nRutgeert score does provide useful validated prognostic\ninformation. This is particularly useful as endoscopic recurrence\nprecedes clinical recurrence. The description here is of stage 2\nfindings - &gt;5 apthous ulcers with normal mucosa between the\nlesions or skip areas of larger lesions or lesions confined to the\nileocolonic anastomosis. This would give a 15-20% chance of\nrecurrence at 3 years.</p>\n\n<p><strong>Reference:</strong></p>\n\n<p>Blum E, Katx JA. Postoperative therapy for Crohn's disease\nInflamm Bowel Dis.2009; 15(3): 463-72.\n &nbsp;</p></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>You have been asked to assess the colon of a patient who has had\nan ileocaecal resection 6 months ago by the colorectal surgeons.\nThe patient is asymptotic but wishes to discuss medical options to\nreduce recurrence with you.</p>\n\n<p>At colonoscopy, you find seven&nbsp;apthous ulcers at the anastomosis\nwith otherwise normal mucosa intervening.</p>\n\n<p>What chance of recurrence would you quote the patient over 3\nyears?</p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"394624\" name=\"rdBtnOption+198991\" class=\"answer-radio\" value=\"394624\"><span>Less than 15%</span></div><div class=\"option\"><input type=\"radio\" id=\"394627\" name=\"rdBtnOption+198991\" class=\"answer-radio\" value=\"394627\"><span class=\"textNotSelected\">50-75%</span></div><div class=\"option\"><input type=\"radio\" id=\"394625\" name=\"rdBtnOption+198991\" class=\"answer-radio\" value=\"394625\"><span>15-20%</span></div><div class=\"option\"><input type=\"radio\" id=\"394628\" name=\"rdBtnOption+198991\" class=\"answer-radio\" value=\"394628\"><span class=\"textNotSelected\">90% or more</span></div><div class=\"option\"><input type=\"radio\" id=\"394626\" name=\"rdBtnOption+198991\" class=\"answer-radio\" value=\"394626\"><span class=\"textNotSelected\">40-50%</span></div></div>",
        "id": 44
    },
    {
        "correctAnswerIndex": 0,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>Upper GI endoscopy</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p>The likely diagnosis is a malignant oesophageal stricture given\nthe patient's age and rapidly progressive nature of the\ndysphagic symptoms.</p>\n\n<p>Endoscopy allows tissue diagnosis from biopsies and brushings\nand has a 98% detection rate in oesophageal carcinoma. Endoscopy\nalso allows dilatation and/or stent placement where dysphagia is\nsevere or the stricture is impassable. Endoscopy would also permit\ndiagnosis of many of the differential causes of dysphagia in this\ncase. It is therefore the the next best investigation here..</p>\n\n<p>Barium swallow is useful but does not have the benefit of\nallowing a histological diagnosis which is key in this case.</p>\n\n<p>Barium swallow may be the initial investigation where dysphagia\nis not severe or if the patient has previously been diagnosed with\na stricture and the site is known. It is also likely to be more\nhelpful where a motility disorder is suspected.</p>\n\n<p>A chest x ray is helpful to identify mediastinal lymphadenopathy\nor aspiration, but endoscopy is the investigation of choice in\nmaking the diagnosis.</p>\n\n<p>An air-fluid level may also be seen on chest x ray but its\npresence indicates obstruction rather than a specific underlying\ncause.</p>\n\n<p>A staging CT scan will be required after the diagnosis is made;\nendoscopy the more important in obtaining histology.</p>\n\n<p>Endoscopic ultrasound (EUS) is better than CT or MRI for\nassessing lymphadenopathy, staging mural invasion and assessing\nsuitability for surgery in patients with oesophageal carcinoma.</p>\n\n<div>Reference:</div>\n\n<ol>\n<li>Atkinson RJ, et al. <cite>Medical Masterclass: Gastroenterology\nand Hepatology.</cite> 2nd ed. London: Royal College of Physicians;\n2008</li>\n\n<li>Travis SPL, et al. <cite>Pocket Consultant\nGastroenterology.</cite> Oxford: Blackwell Publishing; 2005</li>\n</ol></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>A 65-year-old woman presents with a one month history of\nprogressive dysphagia to solids and liquids. She is not sure\nwhether she has lost any weight.</p>\n\n<p>There is no past medical history. She is a smoker but denies\nregular alcohol intake. On examination she appears pale and thin,\nher abdomen is soft and non-tender and there are no palpable\nmasses.</p>\n\n<p>Which of the following is the next best investigation to aid the\ndiagnosis?</p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"397940\" name=\"rdBtnOption+199756\" class=\"answer-radio\" value=\"397940\"><span>Upper GI endoscopy</span></div><div class=\"option\"><input type=\"radio\" id=\"397937\" name=\"rdBtnOption+199756\" class=\"answer-radio\" value=\"397937\"><span class=\"textNotSelected\">Chest x ray</span></div><div class=\"option\"><input type=\"radio\" id=\"397936\" name=\"rdBtnOption+199756\" class=\"answer-radio\" value=\"397936\"><span class=\"textNotSelected\">Barium swallow</span></div><div class=\"option\"><input type=\"radio\" id=\"397939\" name=\"rdBtnOption+199756\" class=\"answer-radio\" value=\"397939\"><span class=\"textNotSelected\">Endoscopic ultrasound (EUS)</span></div><div class=\"option\"><input type=\"radio\" id=\"397938\" name=\"rdBtnOption+199756\" class=\"answer-radio\" value=\"397938\"><span class=\"textNotSelected\">CT chest/abdomen/pelvis</span></div></div>",
        "id": 45
    },
    {
        "correctAnswerIndex": 4,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>Beta-catenin mutation</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p>The following is a description of sporadic FGPs with few polyps\nin a patient over the age of 40. These are caused by beta-catenin\nmutation. Multiple FGPs in a patient under age 40, especially with\ndysplasia should raise a suspicion of FAP and prompt colonic\ninvestigation.</p>\n\n<p>There are some retrospective studies suggesting an association\nof FGPs with PPIs; however, prospective studies have failed to\nconfirm this. Studies suggest that H pylori infection may protect\nagainst development of FGPs and they are not associated with\nPeutz-Jehgers syndrome where surveillance is designed to detect\nadenomas.</p>\n\n<p><strong>Reference:&nbsp;</strong></p>\n\n<p>Goddard F et al. The management of gastric polyps. <em>Gut</em>\n2010;59:1270-1276.\n &nbsp;</p></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>You perform an upper GI endoscopy on a 50-year-old man. You find\nfour&nbsp;fundic gland polyps (FGP).</p>\n\n<p>Which of the following factors are such polyps associated\nwith?</p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"394568\" name=\"rdBtnOption+198979\" class=\"answer-radio\" value=\"394568\"><span>Proton pump inhibitor use</span></div><div class=\"option\"><input type=\"radio\" id=\"394566\" name=\"rdBtnOption+198979\" class=\"answer-radio\" value=\"394566\"><span class=\"textNotSelected\">H pylori infection</span></div><div class=\"option\"><input type=\"radio\" id=\"394565\" name=\"rdBtnOption+198979\" class=\"answer-radio\" value=\"394565\"><span class=\"textNotSelected\">Familial adeonosis polyposis (FAP)</span></div><div class=\"option\"><input type=\"radio\" id=\"394567\" name=\"rdBtnOption+198979\" class=\"answer-radio\" value=\"394567\"><span class=\"textNotSelected\">Peutz-Jehgers syndrome</span></div><div class=\"option\"><input type=\"radio\" id=\"394564\" name=\"rdBtnOption+198979\" class=\"answer-radio\" value=\"394564\"><span>Beta-catenin mutation</span></div></div>",
        "id": 46
    },
    {
        "correctAnswerIndex": 2,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>Alendronic acid</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p><img src=\"asset/13.png\" width=\"466\" height=\"350\"></p>\n\n<p>The endoscopic appearance demonstrates severe, diffuse\noesophagitis in the mid to distal oesophagus. Bisphosphonates are a\nwell-recognised cause of oesophagitis and potentially oesophageal\nstrictures.</p>\n\n<p>All the other drugs listed may potentially worsen or cause\ndyspepsia or reflux but do not directly cause oesophagitis.</p></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>A 79-year-old man is admitted to hospital with severe\nretrosternal pain and dysphagia.&nbsp;</p>\n\n<p>He has a history of chronic obstructive airways disease,\nischaemic heart disease, and polymyalgia rheumatica.&nbsp;</p>\n\n<p>Physical examination reveals mild tenderness in the\nepigastrium.&nbsp; An upper GI endoscopy is performed, from which a\npicture&nbsp;is shown below.&nbsp;</p>\n\n<p>Which of his medications is most likely to have caused this\nappearance?</p>\n\n<p><img src=\"asset/12.png\" width=\"469\" height=\"350\"></p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"398547\" name=\"rdBtnOption+199878\" class=\"answer-radio\" value=\"398547\"><span>Isosorbide mononitrate</span></div><div class=\"option\"><input type=\"radio\" id=\"398548\" name=\"rdBtnOption+199878\" class=\"answer-radio\" value=\"398548\"><span class=\"textNotSelected\">Nifedipine</span></div><div class=\"option\"><input type=\"radio\" id=\"398546\" name=\"rdBtnOption+199878\" class=\"answer-radio\" value=\"398546\"><span>Alendronic acid</span></div><div class=\"option\"><input type=\"radio\" id=\"398549\" name=\"rdBtnOption+199878\" class=\"answer-radio\" value=\"398549\"><span class=\"textNotSelected\">Prednisolone</span></div><div class=\"option\"><input type=\"radio\" id=\"398550\" name=\"rdBtnOption+199878\" class=\"answer-radio\" value=\"398550\"><span class=\"textNotSelected\">Theophylline</span></div></div>",
        "id": 47
    },
    {
        "correctAnswerIndex": 3,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>Duodenal ulceration</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p><img src=\"asset/15.png\" width=\"469\" height=\"348\"></p>\n\n<p>The endoscopic appearances are of two small duodenal ulcers (A)\nwithout evidence of recent haemorrhage.&nbsp; There is some co-existent\nduodenitis.&nbsp; The presence of villi identifies this as the\nduodenum.</p>\n\n<p>The mucosal appearances are not consistent with that of the\nstomach (absence of rugae, paler squamous epithelium rather than\nredder columnar epithelium) or the oesophagus (pale pink\nnon-villous squamous epithelium).</p></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>A 59-year-old woman is admitted to hospital with vomiting and\nepigastric pain.&nbsp; She has a history of ischaemic heart disease and\ndyspepsia.&nbsp;</p>\n\n<p>Her current medications include aspirin, bisoprolol and\nsimvastatin.&nbsp; Physical examination reveals mild tenderness in the\nepigastrium.&nbsp; An upper GI endoscopy is performed a picture from\nwhich is shown below.&nbsp;</p>\n\n<p>What is the underlying diagnosis?</p>\n\n<p><img src=\"asset/14.png\" width=\"469\" height=\"348\"></p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"398534\" name=\"rdBtnOption+199875\" class=\"answer-radio\" value=\"398534\"><span>Oesophageal ulceration</span></div><div class=\"option\"><input type=\"radio\" id=\"398532\" name=\"rdBtnOption+199875\" class=\"answer-radio\" value=\"398532\"><span class=\"textNotSelected\">Gastric carcinoma</span></div><div class=\"option\"><input type=\"radio\" id=\"398533\" name=\"rdBtnOption+199875\" class=\"answer-radio\" value=\"398533\"><span class=\"textNotSelected\">Gastritis</span></div><div class=\"option\"><input type=\"radio\" id=\"398531\" name=\"rdBtnOption+199875\" class=\"answer-radio\" value=\"398531\"><span>Duodenal ulceration</span></div><div class=\"option\"><input type=\"radio\" id=\"398535\" name=\"rdBtnOption+199875\" class=\"answer-radio\" value=\"398535\"><span class=\"textNotSelected\">Oesophagitis</span></div></div>",
        "id": 48
    },
    {
        "correctAnswerIndex": 1,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>A 73-year-old male with a three month history of dyspepsia which has failed to respond to a course of proton pump inhibitors</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n    <div class=\"alert alert-warning fontsize14 w-100\">\n        <span class=\"fontsize18\">Key Learning Points</span>\n        \n\n        \n\n\n\n        <p>Endoscopy</p>\n\n        <ul>\n                <li>Criteria for referral for urgent endoscopy include dyspepsia in a patient aged 55 or above with onset of dyspepsia within one year and persistent symptoms.</li>\n        </ul>\n        \n        \n\n        <div>\n            <label id=\"KLPSuccessMsg\" style=\"display:none\" class=\"text-success fontsize14\">Your preference has been recorded successfully.</label>\n        </div>\n    </div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p>Criteria for referral for urgent endoscopy include</p>\n\n<ul>\n<li>Dysphagia (at any age)</li>\n\n<li>Dyspepsia at any age combined with any one of weight loss,\nanaemia or vomiting</li>\n\n<li>Dyspepsia in a patient aged 55 or above with onset of dyspepsia\nwithin one year and persistent symptoms</li>\n\n<li>Dyspepsia with one of Barrett's oesophagus, family history\nof upper gastrointestinal (GI) carcinoma, pernicious anaemia or\nupper GI surgery more than 20 years ago</li>\n\n<li>Jaundice</li>\n\n<li>Abdominal mass.</li>\n</ul>\n\n<p>With regard to the presented cases, the 56-year-old man has\ndyspepsia with what seems to be an aortic aneurysm. This requires\nan ultrasound and vascular opinion.</p>\n\n<p>In the&nbsp;case of unexplained weight loss, tenesmus and upper right\nmass the problem is likely to be a colonic carcinoma.</p></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>Which one of the following require urgent referral for upper\nendoscopy?</p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"117961\" name=\"rdBtnOption+80738\" class=\"answer-radio\" value=\"117961\"><span>A 62-year-old male with a three month history of unexplained weight\nloss, tenesmus and a right abdominal mass</span></div><div class=\"option\"><input type=\"radio\" id=\"117962\" name=\"rdBtnOption+80738\" class=\"answer-radio\" value=\"117962\"><span>A 73-year-old male with a three month history of dyspepsia which\nhas failed to respond to a course of proton pump inhibitors</span></div><div class=\"option\"><input type=\"radio\" id=\"117958\" name=\"rdBtnOption+80738\" class=\"answer-radio\" value=\"117958\"><span class=\"textNotSelected\">A 35-year-old male who has a history of waterbrash and dyspepsia\nwhich has responded to a course of ranitidine but since stopping\nhas recurred</span></div><div class=\"option\"><input type=\"radio\" id=\"117959\" name=\"rdBtnOption+80738\" class=\"answer-radio\" value=\"117959\"><span class=\"textNotSelected\">A 45-year-old male with a one month history of persistent dyspepsia</span></div><div class=\"option\"><input type=\"radio\" id=\"117960\" name=\"rdBtnOption+80738\" class=\"answer-radio\" value=\"117960\"><span class=\"textNotSelected\">A 56-year-old male with a one month history of dyspepsia and a\npulsatile central abdominal mass</span></div></div>",
        "id": 49
    },
    {
        "correctAnswerIndex": 3,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>Upper gastrointestinal endoscopy with biopsy</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p>The likely diagnosis is <a class=\"bp-link\" target=\"_blank\" href=\"https://bestpractice.bmj.com/topics/en-gb/636\">coeliac disease</a> (evidence of generalised\nsmall bowel disease with pale stools and iron, B<sub>12</sub> and\nfolate deficiencies). Of the options presented upper\ngastrointestinal endoscopy with duodenal biopsies would be the most\nappropriate step in the further evaluation of the patient. In\nclinical practise serological tests would be performed prior to\nthis.</p>\n\n<p>Trial of a gluten free diet should not be instituted prior to\nconfirmation of a diagnosis of <a class=\"bp-link\" target=\"_blank\" href=\"https://bestpractice.bmj.com/topics/en-gb/636\">coeliac disease</a> - it is not a\ndiagnostic manoeuvre and will give rise to false negative\nserological and histological tests.</p>\n\n<p>A small bowel enema may useful in the evaluation of possible\nsmall bowel Crohn's disease or lymphoma.</p>\n\n<p>Colonoscopy would be useful if a large bowel or terminal ileal\npathology (such as Crohn's) was considered the most likely\ndiagnosis.</p>\n\n<p>Metronidazole can be useful in the treatment of peri-anal\nCrohn's disease or small bowel bacterial overgrowth, however a\ntrial of treatment would not usually be instituted until a\ndiagnosis was established.</p></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>A 34-year-old man presents with recurrent, painful mouth ulcers\nand a painful rash at the angles of his mouth. He also describes a\nthree month history of pale stools and intermittent upper abdominal\ndiscomfort.</p>\n\n<p>On examination he is pale and slim with multiple, round, greyish\nulcers in the oral cavity.</p>\n\n<p>His blood tests reveal:</p>\n\n<table class=\"marginTop table table-bordered\">\n<tbody>\n<tr>\n<th>Haemoglobin</th>\n<td>102 g/L</td>\n<td>(130-180)</td>\n</tr>\n\n<tr>\n<th>White cell count</th>\n<td>7.2 \u00d710<sup>9</sup>/L</td>\n<td>(4-11)</td>\n</tr>\n\n<tr>\n<th>Platelets</th>\n<td>387 \u00d710<sup>9</sup>/L</td>\n<td>(150-400)</td>\n</tr>\n\n<tr>\n<th>Mean corpuscular volume</th>\n<td>78 fL</td>\n<td>(80-96)</td>\n</tr>\n\n<tr>\n<th>Red cell distribution width</th>\n<td colspan=\"2\">Raised</td>\n</tr>\n\n<tr>\n<th>Folate</th>\n<td>1.7 ng/mL</td>\n<td>(2.0-11.0)</td>\n</tr>\n\n<tr>\n<th>B<sub>12</sub></th>\n<td>101 pg/mL</td>\n<td>(160-760)</td>\n</tr>\n</tbody>\n</table>\n\n<p>What is the most appropriate next step in the management of this\npatient?</p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"398463\" name=\"rdBtnOption+199861\" class=\"answer-radio\" value=\"398463\"><span>Trial of gluten free diet</span></div><div class=\"option\"><input type=\"radio\" id=\"398461\" name=\"rdBtnOption+199861\" class=\"answer-radio\" value=\"398461\"><span class=\"textNotSelected\">Colonoscopy</span></div><div class=\"option\"><input type=\"radio\" id=\"398464\" name=\"rdBtnOption+199861\" class=\"answer-radio\" value=\"398464\"><span class=\"textNotSelected\">Trial of metronidazole</span></div><div class=\"option\"><input type=\"radio\" id=\"398465\" name=\"rdBtnOption+199861\" class=\"answer-radio\" value=\"398465\"><span>Upper gastrointestinal endoscopy with biopsy</span></div><div class=\"option\"><input type=\"radio\" id=\"398462\" name=\"rdBtnOption+199861\" class=\"answer-radio\" value=\"398462\"><span class=\"textNotSelected\">Small bowel enema</span></div></div>",
        "id": 50
    },
    {
        "correctAnswerIndex": 3,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>Gastric carcinoma</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p><img src=\"asset/17.png\" width=\"354\" height=\"264\"></p>\n\n<p>The endoscopic picture demonstrates a large gastric ulcer and\nevidence of recent haemorrhage with blood visible in the ulcer\ncrater (A).&nbsp; The ulcer has rolled, irregular edges with the\nimpression of a mass at the superior aspect (B).&nbsp; The appearances\nare most consistent with a gastric cancer, particularly in the\ncontext of significant weight loss.</p>\n\n<p>Dieulafoy's lesions are vascular anomalies where a large\ntortuous arteriole erodes through the gastric lining.&nbsp; They may\ncause massive gastrointestinal haemorrhage and can be easily missed\nat endoscopy.&nbsp;</p>\n\n<p>Peptic ulcers tend generally to have a smooth base with\nperpendicular edges, unlike this case.&nbsp;</p>\n\n<p>Mallory-Weiss tears are typically seen in the oesophagus (though\nmay appear in the stomach) and are seen as a split in the\nmucosa.&nbsp;</p>\n\n<p>Varices may occur in the stomach, typically at the\ngastro-oesophageal junction and look like dilated veins.</p></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>A 79-year-old woman is referred to hospital with melaena and\nabdominal pain.&nbsp;</p>\n\n<p>An upper GI endoscopy is performed a picture from which is shown\nbelow.&nbsp;</p>\n\n<p>What is the likely underlying diagnosis?</p>\n\n<p><img src=\"asset/16.png\" width=\"467\" height=\"351\">&nbsp;</p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"398560\" name=\"rdBtnOption+199880\" class=\"answer-radio\" value=\"398560\"><span>Varices</span></div><div class=\"option\"><input type=\"radio\" id=\"398558\" name=\"rdBtnOption+199880\" class=\"answer-radio\" value=\"398558\"><span class=\"textNotSelected\">Mallory-Weiss tear</span></div><div class=\"option\"><input type=\"radio\" id=\"398556\" name=\"rdBtnOption+199880\" class=\"answer-radio\" value=\"398556\"><span class=\"textNotSelected\">Dieulafoy's lesion</span></div><div class=\"option\"><input type=\"radio\" id=\"398557\" name=\"rdBtnOption+199880\" class=\"answer-radio\" value=\"398557\"><span>Gastric carcinoma</span></div><div class=\"option\"><input type=\"radio\" id=\"398559\" name=\"rdBtnOption+199880\" class=\"answer-radio\" value=\"398559\"><span class=\"textNotSelected\">Peptic ulceration</span></div></div>",
        "id": 51
    },
    {
        "correctAnswerIndex": 3,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>Helicobacter eradication therapy</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p>The presentation and histology are consistent with a gut\nassociated lymphoid tissue (GALT) lymphoma or gastric MALToma.</p>\n\n<p>These are almost always associated with and driven by\n<em>Helicobacter pylori</em> infection - a positive\n<em>Campylobacter</em>-like organism test indicates this is\npresent. <em>Helicobacter</em> eradication therapy (antibiotics and\nproton pump inhibition) is effective in producing disease\nregression in around 75% of cases of low-grade disease associated\nwith infection.</p>\n\n<p>Treatment with surgery, chemotherapy or radiotherapy has not\nbeen demonstrated to be superior to antibiotic therapy. Where the\nlatter has failed radiotherapy has been shown to be effective and\nis used where the tumour can be captured in a single radiotherapy\nfield.</p>\n\n<p>Surgery has only a limited role in the treatment of gastric\nMALToma. Chemotherapy is occasionally used in the treatment of GALT\nlymphoma and the regimes used are similar to those used for\nlow-grade non-Hodgkin's lymphoma.</p>\n\n<p>Fluorouracil-based chemotherapy is typically used in the\ntreatment of gastric adenocarcinoma.</p></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>A 67-year-old man undergoes urgent upper gastrointestinal\nendoscopy for investigation of severe, persistent, unexplained\ndyspepsia.</p>\n\n<p>The investigation reveals an area of thickened gastric folds in\nthe fundus. Biopsies taken reveal reactive lymphoid follicles with\na dense lymphoid infiltrate extending into the submucosa and\nepithelium. A <em>Campylobacter</em>-like organism test is\npositive.</p>\n\n<p>What is the most appropriate course of management?</p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"398364\" name=\"rdBtnOption+199841\" class=\"answer-radio\" value=\"398364\"><span>Radiotherapy</span></div><div class=\"option\"><input type=\"radio\" id=\"398365\" name=\"rdBtnOption+199841\" class=\"answer-radio\" value=\"398365\"><span class=\"textNotSelected\">Symptom control</span></div><div class=\"option\"><input type=\"radio\" id=\"398363\" name=\"rdBtnOption+199841\" class=\"answer-radio\" value=\"398363\"><span class=\"textNotSelected\">Partial gastrectomy</span></div><div class=\"option\"><input type=\"radio\" id=\"398362\" name=\"rdBtnOption+199841\" class=\"answer-radio\" value=\"398362\"><span><em>Helicobacter</em> eradication therapy</span></div><div class=\"option\"><input type=\"radio\" id=\"398361\" name=\"rdBtnOption+199841\" class=\"answer-radio\" value=\"398361\"><span class=\"textNotSelected\">Fluorouracil-based chemotherapy</span></div></div>",
        "id": 52
    },
    {
        "correctAnswerIndex": 2,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>CT scan of abdomen and pelvis</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n    <div class=\"alert alert-warning fontsize14 w-100\">\n        <span class=\"fontsize18\">Key Learning Points</span>\n        \n\n        \n\n\n\n        <p>Endoscopy</p>\n\n        <ul>\n                <li>CT scan is investigation of choice to rule out perforation. A high index of suspicion should be maintained following an endoscopy, especially in high risk procedures</li>\n        </ul>\n        \n        \n\n        <div>\n            <label id=\"KLPSuccessMsg\" style=\"display:none\" class=\"text-success fontsize14\">Your preference has been recorded successfully.</label>\n        </div>\n    </div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p>In this case, the clinical presentation may represent a\nperforation or 'post-polypectomy syndrome.' CT scan of the\nabdomen and pelvis can differentiate the two diagnoses via the\nabsence or presence of free air.</p>\n\n<p>Whilst chest x ray can detect free air it is essentially an\noutmoded test with a high false negative rate.</p>\n\n<p>If the diagnosis is post-polypectomy syndrome (pain and\ninflammatory reaction to transmural diathermy injury) then this can\nbe managed by admission and antibiotics/intravenous fluids. If\nperforation is detected, surgery may be required but often\nconservative management will be successful.</p>\n\n<p>The decision will depend on patient fitness, potential histology\nof the resected lesion, CT findings, and clinical\ncondition/progress of the patient.</p></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>You are requested to review a 48-year-old female in Accident and\nEmergency who has had a 2.5cm flat polyp removed from the right\ncolon 3 days ago by EMR performed by a colleague.</p>\n\n<p>She complains of marked right sided abdominal pain. Review of\nthe endoscopy report suggests a straightforward procedure. On\nexamination, she is tender on the right side of her abdomen with\nlocalised guarding in the right iliac fossa. She has an elevated\nwhite cell count of 15 and temperature of 37.7.</p>\n\n<p>What would be the next most appropriate step in her\nmanagement?</p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"394622\" name=\"rdBtnOption+198990\" class=\"answer-radio\" value=\"394622\"><span>Gastrograffin enema</span></div><div class=\"option\"><input type=\"radio\" id=\"394621\" name=\"rdBtnOption+198990\" class=\"answer-radio\" value=\"394621\"><span class=\"textNotSelected\">Erect chest x ray</span></div><div class=\"option\"><input type=\"radio\" id=\"394620\" name=\"rdBtnOption+198990\" class=\"answer-radio\" value=\"394620\"><span>CT scan of abdomen and pelvis</span></div><div class=\"option\"><input type=\"radio\" id=\"394623\" name=\"rdBtnOption+198990\" class=\"answer-radio\" value=\"394623\"><span class=\"textNotSelected\">Refer to surgeons for laparotomy</span></div><div class=\"option\"><input type=\"radio\" id=\"394619\" name=\"rdBtnOption+198990\" class=\"answer-radio\" value=\"394619\"><span class=\"textNotSelected\">Admit for intravenous fluids and broad-spectrum antibiotics</span></div></div>",
        "id": 53
    },
    {
        "correctAnswerIndex": 1,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>None of the above</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p>This man has post-ischaemic, non-oliguric renal failure due to\nsepsis.</p>\n\n<p>There is no clear evidence from clinical trials to support the\nuse of any of the above agents. There is some evidence from animal\nstudies that these agents given early in septicaemia may help\nprevent renal damage.</p>\n\n<p>The use of dopamine, furosemide, and mannitol in acute renal\nfailure remains controversial.</p></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>A 40-year-old male presents for an elective ERCP for a common\nbile duct stone. Post-ERCP he develops acute septicaemia.</p>\n\n<p>Pre-ERCP results:</p>\n\n<table class=\"marginTop table table-bordered\">\n<tbody>\n<tr>\n<th>Serum sodium</th>\n<td>136 mmol/L</td>\n<td>(137-144)</td>\n</tr>\n\n<tr>\n<th>Serum potassium</th>\n<td>4 mmol/L</td>\n<td>(3.5-4.9)</td>\n</tr>\n\n<tr>\n<th>Serum chloride</th>\n<td>100 mmol/L</td>\n<td>(95-107)</td>\n</tr>\n\n<tr>\n<th>Serum bicarbonate</th>\n<td>28 mmol/L</td>\n<td>(20-28)</td>\n</tr>\n\n<tr>\n<th>Serum urea</th>\n<td>4 mmol/L</td>\n<td>(2.5-7.5)</td>\n</tr>\n\n<tr>\n<th>Serum creatinine</th>\n<td>96 \u00b5mol/L</td>\n<td>(60-110)</td>\n</tr>\n</tbody>\n</table>\n\n<p>Post-ERCP results:</p>\n\n<table class=\"marginTop table table-bordered\">\n<tbody>\n<tr>\n<th>Serum sodium</th>\n<td>140 mmol/L</td>\n<td>(137-144)</td>\n</tr>\n\n<tr>\n<th>Serum potassium</th>\n<td>4 mmol/L</td>\n<td>(3.5-4.9)</td>\n</tr>\n\n<tr>\n<th>Serum chloride</th>\n<td>100 mmol/L</td>\n<td>(95-107)</td>\n</tr>\n\n<tr>\n<th>Serum bicarbonate</th>\n<td>16 mmol/L</td>\n<td>(20-28)</td>\n</tr>\n\n<tr>\n<th>Serum urea</th>\n<td>40 mmol/L</td>\n<td>(2.5-7.5)</td>\n</tr>\n\n<tr>\n<th>Serum creatinine</th>\n<td>720 \u00b5mol/L</td>\n<td>(60-110)</td>\n</tr>\n</tbody>\n</table>\n\n<p>All physical findings are normal and his chest is clinically\nclear. He is producing 40 ml of urine per hour.</p>\n\n<p>Based on recent clinical trials, which one of the following is\nevidenced based?</p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"117795\" name=\"rdBtnOption+80705\" class=\"answer-radio\" value=\"117795\"><span>Give low dose dopamine</span></div><div class=\"option\"><input type=\"radio\" id=\"117797\" name=\"rdBtnOption+80705\" class=\"answer-radio\" value=\"117797\"><span>None of the above</span></div><div class=\"option\"><input type=\"radio\" id=\"117794\" name=\"rdBtnOption+80705\" class=\"answer-radio\" value=\"117794\"><span class=\"textNotSelected\">Give high dose furosemide</span></div><div class=\"option\"><input type=\"radio\" id=\"117796\" name=\"rdBtnOption+80705\" class=\"answer-radio\" value=\"117796\"><span class=\"textNotSelected\">Give low dose dopamine, furosemide and mannitol</span></div><div class=\"option\"><input type=\"radio\" id=\"117793\" name=\"rdBtnOption+80705\" class=\"answer-radio\" value=\"117793\"><span class=\"textNotSelected\">Give furosemide and mannitol</span></div></div>",
        "id": 54
    },
    {
        "correctAnswerIndex": 0,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>Fleet Phospho-Soda (De Witt)</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p>In patients with renal transplants, bowel preparation with\nsodium phosphate is contraindicated unless all other have been\nexcluded.</p>\n\n<p>Citra mag contains magnesium carbonate and citric acid.</p>\n\n<p>Fleet phospho-soda is sodium dihydrogen phosphate dehydrate and\ndisodium phosphate dodecahydrate and is therefore\ncontraindicated.</p>\n\n<p>Both Klean-prep and Movi-prep are polyethylene gycol based\npreparations.</p>\n\n<p>Senna is not often used for bowel preparation in isolation.</p></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>You are booking a patient with renal transplant for a\ncolonoscopy.</p>\n\n<p>Which of the following bowel cleansing preparations would be\ncontraindicated?</p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"394590\" name=\"rdBtnOption+198984\" class=\"answer-radio\" value=\"394590\"><span>Fleet Phospho-Soda (De Witt)</span></div><div class=\"option\"><input type=\"radio\" id=\"394593\" name=\"rdBtnOption+198984\" class=\"answer-radio\" value=\"394593\"><span class=\"textNotSelected\">Senna</span></div><div class=\"option\"><input type=\"radio\" id=\"394591\" name=\"rdBtnOption+198984\" class=\"answer-radio\" value=\"394591\"><span class=\"textNotSelected\">Klean Prep (Norgine, Uxbridge, UK)</span></div><div class=\"option\"><input type=\"radio\" id=\"394589\" name=\"rdBtnOption+198984\" class=\"answer-radio\" value=\"394589\"><span class=\"textNotSelected\">Citramag (Sanochemia, Bristol, UK)</span></div><div class=\"option\"><input type=\"radio\" id=\"394592\" name=\"rdBtnOption+198984\" class=\"answer-radio\" value=\"394592\"><span class=\"textNotSelected\">Moviprep (Norgine)</span></div></div>",
        "id": 55
    },
    {
        "correctAnswerIndex": 4,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>A minimum of 90% of ERCPs carried out with therapeutic intent</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p>The Joint Advisory Group (JAG) sets out standards for ERCPs.\nThey recommend that units or networks perform &gt;150 procedures\nper year with a minimum of two qualified ERCP endoscopists to\nprovide a continuous service.</p>\n\n<p>All ERCP performance decisions should have the involvement of a\nconsultant and the completion of the intended therapeutic procedure\nshould occur &gt;80% of the time.</p>\n\n<p>&gt;90% of ERCPs should be carried out with therapeutic\nintent.</p>\n\n<p><strong>References:</strong></p>\n\n<p><a href=\"http://www.thejag.org.uk/downloads/Unit%20Resources/JAG%20Summary%20guide%20to%20quality%20and%20safety%20indicators%20April%202016.pdf\" target=\"_blank\">BSG Quality and Safety Indicators for\nendoscopy.&nbsp;</a>\n &nbsp;</p></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>You are performing an endoscopy unit audit of local ERCP\npractice.</p>\n\n<p>Which of the following is the correct standard that units or\nnetworks should achieve, according to BSG/JAG guidance?</p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"394547\" name=\"rdBtnOption+198975\" class=\"answer-radio\" value=\"394547\"><span>All decisions to perform ERCP should have the involvement of a\ngastroenterology ST3+ or consultant</span></div><div class=\"option\"><input type=\"radio\" id=\"394548\" name=\"rdBtnOption+198975\" class=\"answer-radio\" value=\"394548\"><span class=\"textNotSelected\">Completion of the intended therapeutic procedure in &gt;60% of\ncases</span></div><div class=\"option\"><input type=\"radio\" id=\"394544\" name=\"rdBtnOption+198975\" class=\"answer-radio\" value=\"394544\"><span class=\"textNotSelected\">A minimum of 100 ERCP procedures per year</span></div><div class=\"option\"><input type=\"radio\" id=\"394545\" name=\"rdBtnOption+198975\" class=\"answer-radio\" value=\"394545\"><span class=\"textNotSelected\">A minimum of three qualified endoscopists to provide a continuous\nERCP service</span></div><div class=\"option\"><input type=\"radio\" id=\"394546\" name=\"rdBtnOption+198975\" class=\"answer-radio\" value=\"394546\"><span>A minimum of 90% of ERCPs carried out with therapeutic intent</span></div></div>",
        "id": 56
    },
    {
        "correctAnswerIndex": 0,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>Duodenal ulceration</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p><img src=\"asset/19.png\" width=\"353\" height=\"261\">&nbsp;</p>\n\n<p>The endoscopic appearances are of a reasonably sized duodenal\nulcer (A) with evidence of recent haemorrhage and a visible\nvessel.&nbsp; There is some co-existent duodenitis.&nbsp; The presence of\nvilli identifies this as the duodenum.</p>\n\n<p>The mucosal appearances are not consistent with that of the\nstomach (absence of rugae, paler squamous epithelium rather than\nredder columnar epithelium) or the oesophagus (pale pink\nnon-villous squamous epithelium).</p></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>A 49-year-old homeless man is admitted to hospital with\nmelaena.&nbsp;</p>\n\n<p>He has a history of alcohol excess and hepatitis C.&nbsp;</p>\n\n<p>Physical examination reveals mild tenderness in the\nepigastrium.&nbsp; An upper GI endoscopy is performed a picture from\nwhich is shown below.&nbsp;</p>\n\n<p>What is the underlying diagnosis?</p>\n\n<p><img src=\"asset/18.png\" width=\"353\" height=\"261\">&nbsp;</p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"398537\" name=\"rdBtnOption+199876\" class=\"answer-radio\" value=\"398537\"><span>Duodenal ulceration</span></div><div class=\"option\"><input type=\"radio\" id=\"398539\" name=\"rdBtnOption+199876\" class=\"answer-radio\" value=\"398539\"><span class=\"textNotSelected\">Mallory-Weiss tear</span></div><div class=\"option\"><input type=\"radio\" id=\"398536\" name=\"rdBtnOption+199876\" class=\"answer-radio\" value=\"398536\"><span class=\"textNotSelected\">Dieulafoy's lesion</span></div><div class=\"option\"><input type=\"radio\" id=\"398540\" name=\"rdBtnOption+199876\" class=\"answer-radio\" value=\"398540\"><span class=\"textNotSelected\">Oesophageal varices</span></div><div class=\"option\"><input type=\"radio\" id=\"398538\" name=\"rdBtnOption+199876\" class=\"answer-radio\" value=\"398538\"><span class=\"textNotSelected\">Gastritis</span></div></div>",
        "id": 57
    },
    {
        "correctAnswerIndex": 4,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>Take OCP pill as usual but take extra precautions against pregnancy for 1 week</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p>Current BSG guidance recommends taking additional precautions\nagainst pregnancy for 1 week after bowel prep. Patients taking\nregular non-critical medications should take these 1 hour or more\nbefore their bowel prep and those taking critical medications eg.\nimmunosuppression for transplant may require IV alternatives.&nbsp;</p>\n\n<p><strong>Reference:</strong></p>\n\n<p>Connor A, Tolan D, Hughes S, et al. Consensus guidelines for the\nsafe prescription and administration of oral bowel-cleansing\nagents. <em>Gut</em> (2012).&nbsp;</p></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>You have booked a colonoscopy on a 32-year-old female and\nreceive a message from the endoscopy staff saying she has called\nfor advice on her oral contraceptive pill (OCP) whilst she is\ntaking bowel preparation.</p>\n\n<p>Please select the correct advice you should give from the list\nbelow:</p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"394587\" name=\"rdBtnOption+198983\" class=\"answer-radio\" value=\"394587\"><span>Take OCP pill as usual but take extra precautions against pregnancy\nuntil start of next menstrual period</span></div><div class=\"option\"><input type=\"radio\" id=\"394584\" name=\"rdBtnOption+198983\" class=\"answer-radio\" value=\"394584\"><span class=\"textNotSelected\">Take OCP as usual during bowel preparation without additional\nprecaution</span></div><div class=\"option\"><input type=\"radio\" id=\"394588\" name=\"rdBtnOption+198983\" class=\"answer-radio\" value=\"394588\"><span class=\"textNotSelected\">Take OCP pill as usual but take extra precautions against pregnancy\nuntil end of next menstrual period</span></div><div class=\"option\"><input type=\"radio\" id=\"394585\" name=\"rdBtnOption+198983\" class=\"answer-radio\" value=\"394585\"><span class=\"textNotSelected\">Take OCP pill one hour before taking bowel preparation without\nadditional precautions</span></div><div class=\"option\"><input type=\"radio\" id=\"394586\" name=\"rdBtnOption+198983\" class=\"answer-radio\" value=\"394586\"><span>Take OCP pill as usual but take extra precautions against pregnancy\nfor 1 week</span></div></div>",
        "id": 58
    },
    {
        "correctAnswerIndex": 2,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>Stop warfarin five days prior to endoscopy and ensure INR <1.5</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p>Colonoscopy with polypectomy is an endoscopic procedure which\ncarries a high risk of haemorrhage.</p>\n\n<p>Venous thromboembolism more than three months ago is considered\na low risk clinical scenario for temporary discontinuation of\nanticoagulation.</p>\n\n<p>Where the endoscopic procedure carries a high risk of bleeding\nand the indication for anticoagulation is low risk for\ndiscontinuation then anticoagulation should be discontinued until\nthe INR is &lt;1.5 and restarted post-procedure. Bridging with\nheparin is not required.</p>\n\n<p>Bridging is only recommended if the indication for\nanticoagulation is high risk - for example, mechanical mitral\nvalve, atrial fibrillation (AF) and prosthetic valve, recent venous\nthromboembolism (VTE) (less than three months), thrombophilia.</p>\n\n<p>Low molecular weight heparin (LMWH) is relatively\ncontraindicated in patients with an estimated glomerular filtration\nrate (eGFR) less than 30 mls/min, these patients may require\nadmission for unfractioned heparin (UFH) infusion depending upon\nlocal policy and practice.</p>\n\n<p>Where an endoscopic procedure is associated with a low risk of\nhaemorrhage then the BSG recommends continuation of anticoagulation\nat the current dosage providing an INR within the last seven days\nis within the therapeutic range.</p>\n\n<p>Aiming for a raised but sub-therapeutic INR is not recommended\nin any situation.</p>\n\n<div>Reference:</div>\n\n<p>Veitch AM, Baglin TP, Gershlick AH, et al. <a href=\"http://gut.bmj.com/content/57/9/1322.long\" target=\"_blank\">Guidelines for the management of anticoagulant and\nantiplatelet therapy in patients undergoing endoscopic\nprocedures.</a> <cite>Gut.</cite> 2008;57:1322-9.</p></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>A 47-year-old man is admitted for a colonoscopy and\npolypectomy.</p>\n\n<p>He is currently taking warfarin following diagnosis of a\npulmonary embolism four months ago. He also has chronic renal\nimpairment with an eGFR of 25 mls/min. His most recent INR was\ntaken one week ago and the result was 2.7</p>\n\n<p>According to the 2008 BSG guidelines on the management of\nanticoagulants at endoscopy what is the most appropriate course of\naction?</p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"398324\" name=\"rdBtnOption+199833\" class=\"answer-radio\" value=\"398324\"><span>Stop warfarin and bridge with LMWH when INR &lt;2</span></div><div class=\"option\"><input type=\"radio\" id=\"398322\" name=\"rdBtnOption+199833\" class=\"answer-radio\" value=\"398322\"><span class=\"textNotSelected\">Continue warfarin but at a lower dose aiming for INR 1.5-2</span></div><div class=\"option\"><input type=\"radio\" id=\"398325\" name=\"rdBtnOption+199833\" class=\"answer-radio\" value=\"398325\"><span>Stop warfarin five days prior to endoscopy and ensure INR &lt;1.5</span></div><div class=\"option\"><input type=\"radio\" id=\"398323\" name=\"rdBtnOption+199833\" class=\"answer-radio\" value=\"398323\"><span class=\"textNotSelected\">Stop warfarin and admit for UFH infusion when when INR &lt;2</span></div><div class=\"option\"><input type=\"radio\" id=\"398321\" name=\"rdBtnOption+199833\" class=\"answer-radio\" value=\"398321\"><span class=\"textNotSelected\">Continue warfarin at current dose</span></div></div>",
        "id": 59
    },
    {
        "correctAnswerIndex": 0,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>Omeprazole</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p><img src=\"asset/21.png\" width=\"354\" height=\"267\"></p>\n\n<p>The endoscopic appearances are of a reasonably sized duodenal\nulcer (A) with evidence of recent haemorrhage and a visible vessel.\nThere is some co-existent duodenitis. The presence of villi\nidentifies this as the duodenum. Following endoscopic intervention\npatients should be commenced on a high dose oral or intravenous\nproton pump inhibitor, this reduces the risk of rebleeding.</p>\n\n<p>Amoxicillin and clarithromycin may be indicated if there is\nevidence of <em>Helicobacter pylori</em> infection. This need not\nbe started immediately post-endoscopy but treatment should not be\nunnecessarily delayed.</p>\n\n<p>Propranolol is used in the primary prophylaxis of variceal\nhaemorrhage.</p>\n\n<p>Terlipressin is used in the management of acute variceal\nhaemorrhage.</p>\n\n<p>Tranexamic acid is not routinely used in the management of acute\nupper GI haemorrhage but may sometimes be used where there is\nchronic blood loss from an otherwise untreatable source (for\nexample, gastric cancer).</p></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>A 49-year-old homeless man is admitted to hospital with melaena.\nHe has a history of alcohol excess and hepatitis C.</p>\n\n<p>Physical examination reveals mild tenderness in the epigastrium.\nA therapeutic upper GI endoscopy is performed a picture from which\nis shown below:</p>\n\n<p><img src=\"asset/20.png\" width=\"468\" height=\"354\"></p>\n\n<p>What is the most appropriate treatment to commence immediately\npost-endoscopy?</p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"398542\" name=\"rdBtnOption+199877\" class=\"answer-radio\" value=\"398542\"><span>Omeprazole</span></div><div class=\"option\"><input type=\"radio\" id=\"398541\" name=\"rdBtnOption+199877\" class=\"answer-radio\" value=\"398541\"><span class=\"textNotSelected\">Amoxicillin and clarithromycin</span></div><div class=\"option\"><input type=\"radio\" id=\"398544\" name=\"rdBtnOption+199877\" class=\"answer-radio\" value=\"398544\"><span class=\"textNotSelected\">Terlipressin</span></div><div class=\"option\"><input type=\"radio\" id=\"398545\" name=\"rdBtnOption+199877\" class=\"answer-radio\" value=\"398545\"><span class=\"textNotSelected\">Tranexamic acid</span></div><div class=\"option\"><input type=\"radio\" id=\"398543\" name=\"rdBtnOption+199877\" class=\"answer-radio\" value=\"398543\"><span class=\"textNotSelected\">Propranolol</span></div></div>",
        "id": 60
    },
    {
        "correctAnswerIndex": 1,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>Upper GI endoscopy and colonoscopy</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n    <div class=\"alert alert-warning fontsize14 w-100\">\n        <span class=\"fontsize18\">Key Learning Points</span>\n        \n\n        \n\n\n\n        <p>Endoscopy</p>\n\n        <ul>\n                <li>Microcytic anaemia should prompt investigation for occult GI malignancies</li>\n        </ul>\n        \n        \n\n        <div>\n            <label id=\"KLPSuccessMsg\" style=\"display:none\" class=\"text-success fontsize14\">Your preference has been recorded successfully.</label>\n        </div>\n    </div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p>This man has weight loss and an unexplained microcytic\nanaemia.</p>\n\n<p>The likely site of blood loss is from the GI tract in absence of\nan alternative explanation.</p>\n\n<p>This may be due to an occult GI malignancy and therefore the\ninitial investigations of choice are upper and lower GI\nendoscopy.</p></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>A 69-year-old man is seen in outpatients. He reports weight loss\nof 1 stone over three months but his history is otherwise\nunremarkable.</p>\n\n<p>On examination his abdomen is soft with no palpable masses. A PR\nexamination is normal.</p>\n\n<p>His blood tests show:</p>\n\n<table class=\"marginTop table table-bordered\">\n<tbody>\n<tr>\n<th>Haemoglobin</th>\n<td>80 g/L</td>\n<td>(120-160)</td>\n</tr>\n\n<tr>\n<th>MCV</th>\n<td>70 fL</td>\n<td>(80-96)</td>\n</tr>\n</tbody>\n</table>\n\n<p>Which of the following is the most appropriate first line\ninvestigation for this patient?</p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"118148\" name=\"rdBtnOption+80776\" class=\"answer-radio\" value=\"118148\"><span>Abdominal x ray and colonoscopy</span></div><div class=\"option\"><input type=\"radio\" id=\"118152\" name=\"rdBtnOption+80776\" class=\"answer-radio\" value=\"118152\"><span>Upper GI endoscopy and colonoscopy</span></div><div class=\"option\"><input type=\"radio\" id=\"118151\" name=\"rdBtnOption+80776\" class=\"answer-radio\" value=\"118151\"><span class=\"textNotSelected\">Ultrasound scan of abdomen and colonoscopy</span></div><div class=\"option\"><input type=\"radio\" id=\"118150\" name=\"rdBtnOption+80776\" class=\"answer-radio\" value=\"118150\"><span class=\"textNotSelected\">Sigmoidoscopy and upper GI endoscopy</span></div><div class=\"option\"><input type=\"radio\" id=\"118149\" name=\"rdBtnOption+80776\" class=\"answer-radio\" value=\"118149\"><span class=\"textNotSelected\">CT scan of the abdomen and upper GI endoscopy</span></div></div>",
        "id": 61
    },
    {
        "correctAnswerIndex": 2,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>Ticagrelor should be stopped 5 days before the procedure and aspirin continued</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p>This would qualify as a high-risk procedure, as polypectomy is\nintended. The patient is at low risk of thrombosis as the coronary\nstent is established. BSG guidance would recommend that P2Y12\ninhibitors (clopidogrel, ticagrelor, and prasugrel) are stopped 5\ndays prior and aspirin continued.</p>\n\n<p>If the patient is at high risk of thrombosis a discussion on the\nrisk/benefit ratio should be undertaken with a cardiologist and if\nthe procedure is low risk (planned diagnostic) then P2Y12\ninhibitors continuing can be considered.</p>\n\n<p><strong>Reference:</strong></p>\n\n<p>Veitch AM, et al. Endoscopy in patients on antiplatelet or\nanticoagulant therapy, including direct oral anticoagulants:\nBritish Society of Gastroenterology (BSG) and European Society of\nGastrointestinal Endoscopy (ESGE) guidelines. <em>Gut</em>\n2016;65:374-389.&nbsp;</p></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>One of your patients contacts your secretary about their\nupcoming appointment for a colonoscopy. They had a flexible\nsigmoidoscopy where polyps were found. They have been asked to\nreturn for polypectomy as they take ticagrelor and aspirin for a\ncoronary stent placed three years ago.</p>\n\n<p>What advice should you give regarding these medications?</p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"394563\" name=\"rdBtnOption+198978\" class=\"answer-radio\" value=\"394563\"><span>Ticagrelor should be stopped 10 days prior to the endoscopy but\naspirin should be continued</span></div><div class=\"option\"><input type=\"radio\" id=\"394559\" name=\"rdBtnOption+198978\" class=\"answer-radio\" value=\"394559\"><span class=\"textNotSelected\">Both medications should be stopped 48 hours prior to the procedure</span></div><div class=\"option\"><input type=\"radio\" id=\"394562\" name=\"rdBtnOption+198978\" class=\"answer-radio\" value=\"394562\"><span>Ticagrelor should be stopped 5 days before the procedure and\naspirin continued</span></div><div class=\"option\"><input type=\"radio\" id=\"394560\" name=\"rdBtnOption+198978\" class=\"answer-radio\" value=\"394560\"><span class=\"textNotSelected\">Both medications should be stopped 5 days prior to the procedure</span></div><div class=\"option\"><input type=\"radio\" id=\"394561\" name=\"rdBtnOption+198978\" class=\"answer-radio\" value=\"394561\"><span class=\"textNotSelected\">Continue both medications</span></div></div>",
        "id": 62
    },
    {
        "correctAnswerIndex": 3,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>Oesophageal ulceration</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p><img src=\"asset/23.png\" width=\"355\" height=\"261\"></p>\n\n<p>The endoscopic appearances are of four linear oesophageal ulcers\n(A) with the remainder of the oesophageal mucosa &nbsp;erythematous and\ninflamed with islands of normal mucosa.</p>\n\n<p>The mucosal appearances are not consistent with that of the\nstomach (absence of rugae, paler squamous epithelium rather than\nredder columnar epithelium) or the duodenum (no villi).&nbsp;</p>\n\n<p>Mallory-Weiss tears are usually single and look exactly like\ntears in the epithelium.&nbsp;</p>\n\n<p>There is no narrowing of the lumen to indicate an underlying\nstricture.</p></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>A 29-year-old woman is admitted to hospital with vomiting and\nepigastric pain.&nbsp; More recently there has been some fresh blood in\nthe vomit.&nbsp;</p>\n\n<p>She has a history of alcohol excess and dyspepsia.&nbsp; Physical\nexamination reveals mild tenderness in the epigastrium.&nbsp; An\nultrasound scan of the abdomen is normal and an upper GI endoscopy\nis performed a picture from which is shown below.&nbsp;</p>\n\n<p>What is the underlying diagnosis?</p>\n\n<p><img src=\"asset/22.png\" width=\"469\" height=\"347\">&nbsp;</p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"398529\" name=\"rdBtnOption+199874\" class=\"answer-radio\" value=\"398529\"><span>Oesophageal stricture</span></div><div class=\"option\"><input type=\"radio\" id=\"398527\" name=\"rdBtnOption+199874\" class=\"answer-radio\" value=\"398527\"><span class=\"textNotSelected\">Gastric varices</span></div><div class=\"option\"><input type=\"radio\" id=\"398528\" name=\"rdBtnOption+199874\" class=\"answer-radio\" value=\"398528\"><span class=\"textNotSelected\">Mallory-Weiss tear</span></div><div class=\"option\"><input type=\"radio\" id=\"398530\" name=\"rdBtnOption+199874\" class=\"answer-radio\" value=\"398530\"><span>Oesophageal ulceration</span></div><div class=\"option\"><input type=\"radio\" id=\"398526\" name=\"rdBtnOption+199874\" class=\"answer-radio\" value=\"398526\"><span class=\"textNotSelected\">Duodenal ulceration</span></div></div>",
        "id": 63
    },
    {
        "correctAnswerIndex": 1,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>Malignancy</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p>The combination of relatively young age, extensive and large\nduodenal ulcers, previous <a class=\"bp-link\" target=\"_blank\" href=\"https://bestpractice.bmj.com/topics/en-gb/225\">nephrolithiasis</a> and hypercalcaemia\nstrongly suggests the possibility of <a class=\"bp-link\" target=\"_blank\" href=\"https://bestpractice.bmj.com/topics/en-gb/408\">Zollinger-Ellison syndrome</a> as\npart of multiple endocrine neoplasia type 1. A history of\nepigastric pain and heartburn is common and diarrhoea is present in\nthree-quarters of patients. The mean age of presentation is 43\nyears of age, men are more frequently affected than women.</p>\n\n<p>Peptic ulceration is due to unregulated production of gastrin by\ngastrinomas. These are endocrine tumours which are most frequently\nlocated in the duodenum or pancreas (though ectopic sites such as\nliver and kidney have been described).</p>\n\n<p>The rapid urease test is negative indicating an absence of\nactive <em>Helicobacter pylori</em> infection (though false\nnegatives may occur with recent gastrointestinal haemorrhage);\npositive serology indicates previous exposure but not necessarily\nactive infection.</p>\n\n<p>Although NSAIDs do increase the risk of peptic ulceration\noccasional use of ibuprofen is unlikely to cause such significant\ndisease.</p>\n\n<p>Alcohol may lead to significant gastrointestinal tract\ninflammation but not peptic ulceration.</p>\n\n<p>Hypercalcaemia is not a risk factor for peptic ulcer\ndisease.</p></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>A 39-year-old man is admitted to hospital with a history of\npassing dark stools.</p>\n\n<p>He describes a history of epigastric discomfort and indigestion,\nfor which he has been self-medicating with Gaviscon and\noccasionally ibuprofen, and diarrhoea. He has a previous history of\nrenal stones. He drinks two to three pints of lager per day.</p>\n\n<p>His blood tests show:</p>\n\n<table class=\"marginTop table table-bordered\">\n<tbody>\n<tr>\n<th>Haemoglobin</th>\n<td>102 g/L</td>\n<td>(130-180)</td>\n</tr>\n\n<tr>\n<th>MVC</th>\n<td>76 fL</td>\n<td>(80-96)</td>\n</tr>\n\n<tr>\n<th>White cell count</th>\n<td>7.9 \u00d710<sup>9</sup>/L</td>\n<td>(4-11)</td>\n</tr>\n\n<tr>\n<th>Platelets</th>\n<td>512 \u00d710<sup>9</sup>/L</td>\n<td>(150-400)</td>\n</tr>\n\n<tr>\n<th>Sodium</th>\n<td>135 mmol/L</td>\n<td>(137-144)</td>\n</tr>\n\n<tr>\n<th>Potassium</th>\n<td>3.2 mmol/L</td>\n<td>(3.5-4.9)</td>\n</tr>\n\n<tr>\n<th>Urea</th>\n<td>8.9 mmol/L</td>\n<td>(2.5-7.0)</td>\n</tr>\n\n<tr>\n<th>Creatinine</th>\n<td>104 \u00b5mol/L</td>\n<td>(60-110)</td>\n</tr>\n\n<tr>\n<th>Calcium</th>\n<td>2.81 mmol/L</td>\n<td>(2.2 - 2.6)</td>\n</tr>\n\n<tr>\n<th>Magnesium</th>\n<td>0.79 mmol/L</td>\n<td>(0.75 - 1.0)</td>\n</tr>\n\n<tr>\n<th>Phosphate</th>\n<td>0.98 mmol/L</td>\n<td>(0.8 - 1.4)</td>\n</tr>\n</tbody>\n</table>\n\n<p>Upper gastrointestinal endoscopy reveals multiple, large\nduodenal ulcers without evidence of recent haemorrhage. A rapid\nurease test is negative but <em>Helicobacter pylori</em> serology\nis positive.</p>\n\n<p>When asked, which of the following do you tell him is the most\nsignificant cause of his peptic ulcer disease?</p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"398201\" name=\"rdBtnOption+199809\" class=\"answer-radio\" value=\"398201\"><span>Alcohol</span></div><div class=\"option\"><input type=\"radio\" id=\"398204\" name=\"rdBtnOption+199809\" class=\"answer-radio\" value=\"398204\"><span>Malignancy</span></div><div class=\"option\"><input type=\"radio\" id=\"398202\" name=\"rdBtnOption+199809\" class=\"answer-radio\" value=\"398202\"><span class=\"textNotSelected\"><em>Helicobacter pylori</em> infection</span></div><div class=\"option\"><input type=\"radio\" id=\"398205\" name=\"rdBtnOption+199809\" class=\"answer-radio\" value=\"398205\"><span class=\"textNotSelected\">Non-steroidal anti-inflammatory drugs</span></div><div class=\"option\"><input type=\"radio\" id=\"398203\" name=\"rdBtnOption+199809\" class=\"answer-radio\" value=\"398203\"><span class=\"textNotSelected\">Hypercalcaemia</span></div></div>",
        "id": 64
    },
    {
        "correctAnswerIndex": 4,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>Capsule endoscopy</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p>ESGE guidance (endorsed by the BSG) recommends capsule endoscopy\nas the first line investigation for obscure GI bleeding. They do\nnot recommend repetition of previously negative endoscopies and\nwould reserve enteroscopy for confirmed lesions after capsule\nendoscopy.</p>\n\n<p><strong>Reference:</strong></p>\n\n<p>Pennazio M et al. Small-bowel capsule endoscopy and\ndevice-assisted enteroscopy for diagnosis and treatment of small\nbowel disorders: European Society of Gastrointestinal Endoscopy\n(ESGE) Clinical Guideline. <em>Endoscopy</em> 2015; 47:\n352-376.</p></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>A 50-year-old man presents with iron deficiency anaemia. Upper\nand lower GI endoscopy are both normal. He remains anaemic on oral\niron supplementation and his GP recontacts you to tell you that his\nfaecal occult blood test is positive.</p>\n\n<p>What would be the next investigation for obscure GI bleeding in\nthis case?</p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"394576\" name=\"rdBtnOption+198981\" class=\"answer-radio\" value=\"394576\"><span>Push enteroscopy</span></div><div class=\"option\"><input type=\"radio\" id=\"394578\" name=\"rdBtnOption+198981\" class=\"answer-radio\" value=\"394578\"><span class=\"textNotSelected\">Repeat upper GI endoscopy and colonoscopy</span></div><div class=\"option\"><input type=\"radio\" id=\"394577\" name=\"rdBtnOption+198981\" class=\"answer-radio\" value=\"394577\"><span class=\"textNotSelected\">Repeat upper GI endoscopy</span></div><div class=\"option\"><input type=\"radio\" id=\"394575\" name=\"rdBtnOption+198981\" class=\"answer-radio\" value=\"394575\"><span class=\"textNotSelected\">Device-assisted enteroscopy (eg. double balloon endoscopy)</span></div><div class=\"option\"><input type=\"radio\" id=\"394574\" name=\"rdBtnOption+198981\" class=\"answer-radio\" value=\"394574\"><span>Capsule endoscopy</span></div></div>",
        "id": 65
    },
    {
        "correctAnswerIndex": 3,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>Discharge</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p>FAP can involve the upper GI tract especially the duodenum, and\nmalignancy can occur. Oesophagogastroduodenoscopy (OGD)\nsurveillance is recommended. In this case there is no abnormality\nnoted.</p>\n\n<p>Upper gastrointestinal bleeding can be scored (Rockall) and\ndivided into high and low risk.</p>\n\n<p>The most likely diagnosis here is alcohol induced <a class=\"bp-link\" target=\"_blank\" href=\"https://bestpractice.bmj.com/topics/en-gb/816\">gastritis</a> or a\nMallory-Weiss tear. There are no features of concern here and he\ncan safely be discharged. The patient would need further\ninvestigation if there was ongoing blood loss.</p>\n\n<p>The <a href=\"http://gut.bmj.com/content/38/3/316.full.pdf\" target=\"_blank\">Rockall score</a> indicates the risk of death after\nacute upper gastrointestinal haemorrhage. The score can be used\nwith or without the results of endoscopy or emergency surgery.</p></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>An 18-year-old man was seen on a Friday night at the Emergency\nDepartment. He had been brought in by his friends who reported that\nhe had collapsed in a public bar after vomiting. Friends had noted\nthat the vomitus was bright red.</p>\n\n<p>He reported a history of familial adenomatous polyposis (FAP)\nfor which he had undergone a prophylactic colectomy with the\nformation of an ileoanal pouch some years previously.</p>\n\n<p>On examination he looked well, blood pressure 120/80 mm/Hg with\nno postural drop, pulse rate 70 beats per minute. The remainder of\nthe examination including per rectal examination was\nunremarkable.</p>\n\n<table class=\"marginTop table table-bordered\">\n<tbody>\n<tr>\n<th>Haemoglobin</th>\n<td>139 g/L</td>\n<td>(130-180)</td>\n</tr>\n\n<tr>\n<th>White blood cells</th>\n<td>6 \u00d710<sup>9</sup>/L</td>\n<td>(4-11)</td>\n</tr>\n\n<tr>\n<th>Platelets</th>\n<td>200 \u00d710<sup>9</sup>/L</td>\n<td>(150-400)</td>\n</tr>\n</tbody>\n</table>\n\n<p>An upper gastrointestinal (GI) endoscopy was normal.</p>\n\n<p>Which should be the next step in his management?</p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"118112\" name=\"rdBtnOption+80768\" class=\"answer-radio\" value=\"118112\"><span>Repeat upper gastrointestinal endoscopy</span></div><div class=\"option\"><input type=\"radio\" id=\"118108\" name=\"rdBtnOption+80768\" class=\"answer-radio\" value=\"118108\"><span class=\"textNotSelected\">Colonoscopy</span></div><div class=\"option\"><input type=\"radio\" id=\"118110\" name=\"rdBtnOption+80768\" class=\"answer-radio\" value=\"118110\"><span class=\"textNotSelected\">Enteroscopy</span></div><div class=\"option\"><input type=\"radio\" id=\"118109\" name=\"rdBtnOption+80768\" class=\"answer-radio\" value=\"118109\"><span>Discharge</span></div><div class=\"option\"><input type=\"radio\" id=\"118111\" name=\"rdBtnOption+80768\" class=\"answer-radio\" value=\"118111\"><span class=\"textNotSelected\">Referral to surgical team</span></div></div>",
        "id": 66
    },
    {
        "correctAnswerIndex": 2,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>No antibiotic prophylaxis</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p>BSG guidance now recommends antibiotic prophylaxis for endoscopy\nin very limited circumstances. In neutropenia, prophylactic\nantibiotics are only recommended in severe neutropenia (neutrophil\ncount &lt;0.5x109l) where a high-risk procedure such as\nsclerotherapy or banding is expected.</p>\n\n<p><strong>Reference:</strong></p>\n\n<p>Allison MC. Antibiotic prophylaxis in gastrointestinal\nendoscopy. <em>Gut</em> 2009;58:869-880.</p></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>You are undertaking an emergency diagnostic endoscopy on a\npatient who has been admitted to the haematology ward as an\nemergency with epigastric pain whilst receiving chemotherapy for\nhaematological malignancy.</p>\n\n<p>Their CT scan is normal. They are neutropenic with a&nbsp;neutrophil\ncount of 0.8x109l.</p>\n\n<p>Which antibiotic prophylaxis regime would be most appropriate\nfor this patient?</p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"394579\" name=\"rdBtnOption+198982\" class=\"answer-radio\" value=\"394579\"><span>Ciprofloxacin 500 mg PO</span></div><div class=\"option\"><input type=\"radio\" id=\"394581\" name=\"rdBtnOption+198982\" class=\"answer-radio\" value=\"394581\"><span class=\"textNotSelected\">Meropenem 1 g IV</span></div><div class=\"option\"><input type=\"radio\" id=\"394582\" name=\"rdBtnOption+198982\" class=\"answer-radio\" value=\"394582\"><span>No antibiotic prophylaxis</span></div><div class=\"option\"><input type=\"radio\" id=\"394580\" name=\"rdBtnOption+198982\" class=\"answer-radio\" value=\"394580\"><span class=\"textNotSelected\">Ciprofloxacin 750 mg IV</span></div><div class=\"option\"><input type=\"radio\" id=\"394583\" name=\"rdBtnOption+198982\" class=\"answer-radio\" value=\"394583\"><span class=\"textNotSelected\">Piperacillin/tazobactam 4.5 g IV</span></div></div>",
        "id": 67
    },
    {
        "correctAnswerIndex": 2,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>Further endoscopy every three to five years with biopsies</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p>The 2013 British Society of Gastroenterology (BSG) guidance on\nendoscopic surveillance of Barrett's oesophagus recommends that\nendoscopy should be performed every three to five years for\npatients with a &lt;3 cm segment of Barrett's without\ndysplasia. For longer segment Barrett's (&gt;3 cm) without\ndysplasia the recommended interval between endoscopies is shorter\n(two to three years).</p>\n\n<p>Patients with low grade dysplasia should have high dose acid\nsuppression and endoscopy six monthly until dysplastic change\nresolves (then as per no dysplasia) or high grade dysplasia is\nnoted.</p>\n\n<p>Patients with high grade dysplasia should be discussed in an MDT\nfor consideration of more aggressive treatment endoscopically (for\nexample, EMR) or even surgically.</p>\n\n<div>Reference:</div>\n\n<p>Fitzgerald RC, di Pietro M, Ragunath K, et al. <a href=\"http://gut.bmj.com/content/63/1/7.long\" target=\"_blank\">British Society of Gastroenterology guidelines on\nthe diagnosis and management of Barrett's oesophagus.</a>\n<cite>Gut.</cite> 2014;63:7-42.</p></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>A 64-year-old man who has a longstanding history of reflux is\nreferred by his GP to the gastroenterology clinic. His symptoms are\nresistant to PPI therapy.</p>\n\n<p>You arrange an endoscopy which demonstrates oesophagitis with a\n2 cm segment of Barrett's oesophagus. At the follow up\nappointment the histology report confirms Barrett's but there\nis no dysplasia. The patient asks you about follow up\nendoscopy.</p>\n\n<p>What surveillance interval period would be most appropriate in\nthis patient?</p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"398062\" name=\"rdBtnOption+199781\" class=\"answer-radio\" value=\"398062\"><span>Further endoscopy every six months with biopsies</span></div><div class=\"option\"><input type=\"radio\" id=\"398063\" name=\"rdBtnOption+199781\" class=\"answer-radio\" value=\"398063\"><span class=\"textNotSelected\">Further endoscopy every two to three years with biopsies</span></div><div class=\"option\"><input type=\"radio\" id=\"398064\" name=\"rdBtnOption+199781\" class=\"answer-radio\" value=\"398064\"><span>Further endoscopy every three to five years with biopsies</span></div><div class=\"option\"><input type=\"radio\" id=\"398061\" name=\"rdBtnOption+199781\" class=\"answer-radio\" value=\"398061\"><span class=\"textNotSelected\">Arrange for second pathology opinion</span></div><div class=\"option\"><input type=\"radio\" id=\"398065\" name=\"rdBtnOption+199781\" class=\"answer-radio\" value=\"398065\"><span class=\"textNotSelected\">No further endoscopy required</span></div></div>",
        "id": 68
    },
    {
        "correctAnswerIndex": 0,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>Capacity to consent is demonstrated by the ability to understand, weigh up, and retain the information provided to the patient and communicate their decision</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p>The Mental Capacity Act starts from the premise that all adults\n(aged 16 or over) are presumed to have the capacity to consent\nunless they are unable to fulfil the criteria: to understand, weigh\nup and retain, the information provided to the patient and\ncommunicate their decision.</p>\n\n<p>As far as possible, individuals should be supported to make\ntheir own decisions and capacity can vary for different decisions\nso a previous decision about a lack of capacity does not preclude\ncapacity in the future.</p>\n\n<p>Where there is not capacity guidance for 'best\ninterests', decision making is provided.</p></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>You are consenting a patient, who has sustained a prior brain\ninjury, for an endoscopy. You are abiding by the Mental Capacity\nAct to make a decision on whether the patient is able to give\ninformed consent.</p>\n\n<p>Which of the following statements best applies to the Mental\nCapacity Act?</p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"394541\" name=\"rdBtnOption+198974\" class=\"answer-radio\" value=\"394541\"><span>Capacity to consent is demonstrated by the ability to understand,\nweigh up, and retain the information provided to the patient and\ncommunicate their decision</span></div><div class=\"option\"><input type=\"radio\" id=\"394542\" name=\"rdBtnOption+198974\" class=\"answer-radio\" value=\"394542\"><span class=\"textNotSelected\">In the absence of capacity, consent should be sought from the next\nof kin</span></div><div class=\"option\"><input type=\"radio\" id=\"394539\" name=\"rdBtnOption+198974\" class=\"answer-radio\" value=\"394539\"><span class=\"textNotSelected\">A patient who is physically unable to sign a consent form would be\njudged not to have capacity</span></div><div class=\"option\"><input type=\"radio\" id=\"394540\" name=\"rdBtnOption+198974\" class=\"answer-radio\" value=\"394540\"><span class=\"textNotSelected\">A previous decision by a clinician that there is not capacity to\ngive consent stands for future procedures</span></div><div class=\"option\"><input type=\"radio\" id=\"394543\" name=\"rdBtnOption+198974\" class=\"answer-radio\" value=\"394543\"><span class=\"textNotSelected\">It applies to adults aged 18 or over</span></div></div>",
        "id": 69
    },
    {
        "correctAnswerIndex": 3,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>80%</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p>Kikuchi staging judges level of submucosal invasion of flat (T1)\npolyp cancers (as opposed to stalked polyp cancers where the\nHaggitt stage would be used). Invasion is judged in thirds with\nreference to the deeper muscular layer. sm1 would be less than\none-third invasion, sm2 - one-third to two-thirds and sm3 between\ntwo-thirds and full submucosal depth without penetration of the\nmuscularis mucosa layer.</p>\n\n<p>Factors predicting local recurrence at 3 years are size of\nlesion, Kikuchi grade, and lymphovascular invasion for completely\nexcised lesions. Depending on the lymphovascular invasion status in\nthis case, the 3 year recurrence would be between 10.5 and 17.8%.\nSurgical resection is usually advised for all sm3 lesions in a fit\npatient. It is worth noting that the corollary of 10-17% residual\ndisease is that &gt;80% of patients will be exposed to the risk of\nsurgery with no additional oncologic benefit.</p>\n\n<p><strong>Reference:&nbsp;</strong></p>\n\n<p>Williams JG et al. Management of the malignant colorectal polyp:\nACPGBI position statement.<em>Colorectal Disease</em>.15 (Suppl.\n2), 1-38</p></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>A patient comes to see you in clinic. You recently performed an\nendoscopic mucosal resection (EMR) of a suspicious rectal polyp.\nPathology has shown an 8mm flat polyp (T1) adenocarcinoma, Kikuchi\nsm 3 with clear margins. The patient wishes to know the chances\nthat the EMR has completely cured him of his cancer.</p>\n\n<p>What would be the most appropriate figure?</p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"394524\" name=\"rdBtnOption+198971\" class=\"answer-radio\" value=\"394524\"><span>10%</span></div><div class=\"option\"><input type=\"radio\" id=\"394527\" name=\"rdBtnOption+198971\" class=\"answer-radio\" value=\"394527\"><span class=\"textNotSelected\">67%</span></div><div class=\"option\"><input type=\"radio\" id=\"394525\" name=\"rdBtnOption+198971\" class=\"answer-radio\" value=\"394525\"><span class=\"textNotSelected\">30%</span></div><div class=\"option\"><input type=\"radio\" id=\"394528\" name=\"rdBtnOption+198971\" class=\"answer-radio\" value=\"394528\"><span>80%</span></div><div class=\"option\"><input type=\"radio\" id=\"394526\" name=\"rdBtnOption+198971\" class=\"answer-radio\" value=\"394526\"><span class=\"textNotSelected\">50%</span></div></div>",
        "id": 70
    },
    {
        "correctAnswerIndex": 4,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>Terlipressin</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p>Terlipressin is a powerful splanchnic vasoconstrictor. When\nadministered prior to endoscopy in patients with likely variceal\nbleeding (upper gastrointestinal bleeding in patients with known\nliver disease or varices or stigmata of chronic liver disease on\nexamination) it has been shown to improve mortality and the\nachievement of haemostasis (including a reduction in the number of\nprocedures required for uncontrolled bleeding). As a\nvasoconstrictor its administration is contraindicated in those with\na history of ischaemic heart disease as it may precipitate\nmyocardial ischaemia.</p>\n\n<p>Balloon tamponade (for example, using a Sengstaken-Blakemore\ntube) may be used as a holding measure in situations where, for\nwhatever reason, a definitive procedure cannot be performed to\ncontrol bleeding (for example, endoscopy or transjugular\nintrahepatic portosystemic shunting). It is generally very\neffective in achieving control of variceal bleeding.</p>\n\n<p>Nasogastric tube insertion may be undertaken in the context of\nupper gastrointestinal bleeding to evaluate the presence and volume\nof blood and to reduce the risk of aspiration where vomiting is\npresent and the conscious level depressed. There is no diagnostic\nor therapeutic indication in this case and tube insertion is\nrelatively contraindicated in those with oesophageal varices.</p>\n\n<p>There is no proven role for the administration of intravenous\nproton pump inhibitors prior to endoscopy in either variceal or\nnon-variceal bleeding. Their use is proven in those individuals\nwith peptic ulcer bleeding with stigmata of recent haemorrhage (or\nrequiring intervention) at endoscopy.</p>\n\n<p>Oral sucralfate has no proven role in the management of\ngastrointestinal bleeding. It is sometimes used in the management\nof <a class=\"bp-link\" target=\"_blank\" href=\"https://bestpractice.bmj.com/topics/en-gb/80\">peptic ulcer disease</a> and gastro-oesophageal reflux or\nprophylaxis against the development of stress ulcers in unwell\npatients.</p></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>A 33-year-old man is admitted to hospital vomiting fresh red\nblood and passing dark, black stools. He gives no previous medical\nhistory and denies taking any regular, over-the-counter or illicit\ndrugs.</p>\n\n<p>On examination he is pale, jaundiced, tachycardic and\nhypotensive. He has several spider naevi and a paucity of body\nhair.</p>\n\n<p>Following appropriate resuscitation what is the most appropriate\ntreatment whilst awaiting urgent endoscopy?</p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"398181\" name=\"rdBtnOption+199805\" class=\"answer-radio\" value=\"398181\"><span>Balloon tamponade</span></div><div class=\"option\"><input type=\"radio\" id=\"398182\" name=\"rdBtnOption+199805\" class=\"answer-radio\" value=\"398182\"><span class=\"textNotSelected\">Intravenous proton protein pump inhibitor</span></div><div class=\"option\"><input type=\"radio\" id=\"398184\" name=\"rdBtnOption+199805\" class=\"answer-radio\" value=\"398184\"><span class=\"textNotSelected\">Oral sucralfate</span></div><div class=\"option\"><input type=\"radio\" id=\"398183\" name=\"rdBtnOption+199805\" class=\"answer-radio\" value=\"398183\"><span class=\"textNotSelected\">Nasogastric tube placement and aspiration</span></div><div class=\"option\"><input type=\"radio\" id=\"398185\" name=\"rdBtnOption+199805\" class=\"answer-radio\" value=\"398185\"><span>Terlipressin</span></div></div>",
        "id": 71
    },
    {
        "correctAnswerIndex": 2,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>Identification of cancers in the correct segment of the colon in 85% of cases</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n    <div class=\"alert alert-warning fontsize14 w-100\">\n        <span class=\"fontsize18\">Key Learning Points</span>\n        \n\n        \n\n\n\n        <p>Endoscopy</p>\n\n        <ul>\n                <li> </li>\n        </ul>\n        \n        \n\n        <div>\n            <label id=\"KLPSuccessMsg\" style=\"display:none\" class=\"text-success fontsize14\">Your preference has been recorded successfully.</label>\n        </div>\n    </div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p>The national bowel cancer screening programme (BCSP) is tightly\nregulated both to ensure diagnostic quality and also to minimise\nharm to participants who have a false positive at the faecal occult\nblood stage of screening.</p>\n\n<p>Three serious complications in 2000 colonoscopies is less than\nthe standard of &lt;3 per 1000 colonoscopies.</p>\n\n<p>Adenoma and cancer detection rates should be &gt;35 and &gt;11%\nrespectively in screening colonoscopies (&gt;0.6 and &gt;0.2% in\nthose screened).</p>\n\n<p>Post-polypectomy perforation rates should be less than 1 in 500.\nThe figure of concern is correct identification of the colonic\nsegment which should be greater than 90%.</p>\n\n<p>Tattooing of suspected malignant polyps is mandatory in 100% in\nBCSP; however, this relies on a clinical suspicion of\nmalignancy.</p></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>One of the bowel cancer screening nurses presents data regarding\nthe faecal&nbsp;occult blood test (FOBT) screening programme in your\nunit. She presents data for two thousand screening\ncolonoscopies.</p>\n\n<p>Which of the following audit findings would represent an area of\nconcern for current practice?</p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"394557\" name=\"rdBtnOption+198977\" class=\"answer-radio\" value=\"394557\"><span>Post polypectomy perforation rate of 1 in 2000 colonoscopies</span></div><div class=\"option\"><input type=\"radio\" id=\"394558\" name=\"rdBtnOption+198977\" class=\"answer-radio\" value=\"394558\"><span class=\"textNotSelected\">Three serious colonoscopic complications requiring hospitalisation\nin the series</span></div><div class=\"option\"><input type=\"radio\" id=\"394556\" name=\"rdBtnOption+198977\" class=\"answer-radio\" value=\"394556\"><span>Identification of cancers in the correct segment of the colon in\n85% of cases</span></div><div class=\"option\"><input type=\"radio\" id=\"394554\" name=\"rdBtnOption+198977\" class=\"answer-radio\" value=\"394554\"><span class=\"textNotSelected\">Adenoma detection rate of 42% in screening colonoscopies</span></div><div class=\"option\"><input type=\"radio\" id=\"394555\" name=\"rdBtnOption+198977\" class=\"answer-radio\" value=\"394555\"><span class=\"textNotSelected\">Cancer detection rate of 14% in screening colonoscopies</span></div></div>",
        "id": 72
    },
    {
        "correctAnswerIndex": 1,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>6 months</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p>Gastric adenomas are precursors of gastric cancer. They are\noften solitary. Neoplastic progression is greater with polyps\nlarger than 2 cm in diameter and occurs in 28.5-40% of villous\nadenomas and 5% of tubular adenomas. There is a strong association\nbetween gastric adenoma and synchronous or metachronous gastric\nadenocarcinoma.</p>\n\n<p>Current BSG guidance suggests that repeat OGD is arranged for\nhigh-risk adenomas at 6 months and 1 year for all other adenomas.\nHigh-grade dysplasia and a potentially incomplete resection (&lt;1\nmm) would both be high-risk features.</p>\n\n<p><strong>Reference:</strong></p>\n\n<p>Goddard F et al. The management of gastric polyps. <em>Gut</em>\n2010;59:1270-1276.</p></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>You perform an upper GI endoscopy on a 62-year-old man. You find\na 1.5 cm single gastric polyp which you resect. Otherwise, the\nstomach is normal. The pathology shows a tubulo-villous adenoma\nwith high-grade dysplasia. Adenoma extends to within 1 mm of the\nreaction margin.</p>\n\n<p>When should you arrange repeat endoscopy?</p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"394569\" name=\"rdBtnOption+198980\" class=\"answer-radio\" value=\"394569\"><span>6 weeks</span></div><div class=\"option\"><input type=\"radio\" id=\"394570\" name=\"rdBtnOption+198980\" class=\"answer-radio\" value=\"394570\"><span>6 months</span></div><div class=\"option\"><input type=\"radio\" id=\"394573\" name=\"rdBtnOption+198980\" class=\"answer-radio\" value=\"394573\"><span class=\"textNotSelected\">No further endoscopy required</span></div><div class=\"option\"><input type=\"radio\" id=\"394571\" name=\"rdBtnOption+198980\" class=\"answer-radio\" value=\"394571\"><span class=\"textNotSelected\">1 year</span></div><div class=\"option\"><input type=\"radio\" id=\"394572\" name=\"rdBtnOption+198980\" class=\"answer-radio\" value=\"394572\"><span class=\"textNotSelected\">2 years</span></div></div>",
        "id": 73
    },
    {
        "correctAnswerIndex": 4,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>Hyperplastic polyp</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p>This question refers to the Kudo classification of pit pattern\nwhich can be used to provide 'optical biopsy' of lesions in\nthe colon, although clearly not a substitute for definitive\nhistology. 'Asteroid' pit patterns are the hallmark of\nhyper plastic polyps and the location is also typical here.\nUsually, these are paler than the surrounding mucosa.</p>\n\n<p><strong>Reference:</strong></p>\n\n<p>Kudo S, Tamura S, Nakajima T, Yamano H, Kusaka H, Wa- tanabe H.\nDiagnosis of colorectal tumorous lesions by magnifying endoscopy.\n<em>Gastrointest Endosc</em> 1996; 44: 8-14.</p></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>You perform a colonoscopy where you detect an 8mm rectal polyp.\nYou examine the pit pattern in detail and find the pits to be\nenlarged and 'asteroid' in nature. The polyp is resected\nand sent for histology.</p>\n\n<p>What would you expect the final histology to confirm?</p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"394532\" name=\"rdBtnOption+198972\" class=\"answer-radio\" value=\"394532\"><span>Tubular adenoma</span></div><div class=\"option\"><input type=\"radio\" id=\"394531\" name=\"rdBtnOption+198972\" class=\"answer-radio\" value=\"394531\"><span class=\"textNotSelected\">Invasive carcinoma</span></div><div class=\"option\"><input type=\"radio\" id=\"394533\" name=\"rdBtnOption+198972\" class=\"answer-radio\" value=\"394533\"><span class=\"textNotSelected\">Tubulo-villous adenoma</span></div><div class=\"option\"><input type=\"radio\" id=\"394529\" name=\"rdBtnOption+198972\" class=\"answer-radio\" value=\"394529\"><span class=\"textNotSelected\">Hamartoma</span></div><div class=\"option\"><input type=\"radio\" id=\"394530\" name=\"rdBtnOption+198972\" class=\"answer-radio\" value=\"394530\"><span>Hyperplastic polyp</span></div></div>",
        "id": 74
    },
    {
        "correctAnswerIndex": 4,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>Stop clopidogrel seven days prior to procedure, continue aspirin</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p>This lady is likely to need a sphincterotomy at ERCP in order\naid removal of her CBD stones and help prevent their\nrecurrence.</p>\n\n<p>ERCP with sphincterotomy is an endoscopic procedure with a high\nrisk of haemorrhage.</p>\n\n<p>Clopidogrel is associated with a much higher risk of bleeding\nthan aspirin.</p>\n\n<p>Ischaemic heart disease without endovascular stents is\nconsidered a low risk condition for the temporary discontinuation\nof clopidogrel.</p>\n\n<p>Aspirin and clopidogrel are both irreversible inhibitors of\nplatelet function and when they are to be discontinued must be\nstopped at least seven days prior to procedure to significantly\nreduce the risk of associated bleeding.</p>\n\n<p>Aspirin is not associated with the same degree of bleeding as\nclopidogrel and may be continued in those already taking it even\nprior to endoscopic intervention with a high risk of bleeding.</p>\n\n<p>In those not already prescribed aspirin it should be considered\nas a bridging agent if clopidogrel must be discontinued.</p>\n\n<p>Patients with coronary stents in place are at high risk of\nthrombosis if clopidogrel is discontinued. Their management should\nbe in conjunction with a cardiologist.</p>\n\n<p>The risk of thrombosis and thus stopping clopidogrel is reduced\nif more than 12 months have elapsed since insertion of a\ndrug-eluting stent or more than one month after insertion of a\nbare-metal stent.</p>\n\n<div>Further Reading:</div>\n\n<p>Veitch AM, et al. <a href=\"http://www.bsg.org.uk/pdf_word_docs/anticoagulant_08.pdf\" target=\"_blank\">Guidelines for the management of anticoagulant and\nantiplatelet therapy in patients undergoing endoscopic\nprocedures.</a> <cite>Gut.</cite> 2008;57:1322-9.</p></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>A 49-year-old lady is admitted for therapeutic ERCP for the\nremoval of several large common bile duct stones.</p>\n\n<p>She has a history of ischaemic heart disease and is currently\ntaking aspirin and clopidogrel as secondary prophylaxis. Her other\nmedications include simvastatin, lansoprazole and bisoprolol and\nshe has no known drug allergies.</p>\n\n<p>According to the 2008 BSG guidelines on the management of\nanticoagulants at endoscopy what is the most appropriate course of\naction?</p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"398329\" name=\"rdBtnOption+199834\" class=\"answer-radio\" value=\"398329\"><span>Stop both aspirin and clopidogrel seven days prior to procedure</span></div><div class=\"option\"><input type=\"radio\" id=\"398326\" name=\"rdBtnOption+199834\" class=\"answer-radio\" value=\"398326\"><span class=\"textNotSelected\">Continue clopidogrel and aspirin</span></div><div class=\"option\"><input type=\"radio\" id=\"398327\" name=\"rdBtnOption+199834\" class=\"answer-radio\" value=\"398327\"><span class=\"textNotSelected\">Omit both clopidogrel and aspirin on the day of procedure</span></div><div class=\"option\"><input type=\"radio\" id=\"398328\" name=\"rdBtnOption+199834\" class=\"answer-radio\" value=\"398328\"><span class=\"textNotSelected\">Stop aspirin seven days prior to procedure and continue clopidogrel</span></div><div class=\"option\"><input type=\"radio\" id=\"398330\" name=\"rdBtnOption+199834\" class=\"answer-radio\" value=\"398330\"><span>Stop clopidogrel seven days prior to procedure, continue aspirin</span></div></div>",
        "id": 75
    },
    {
        "correctAnswerIndex": 0,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>Repeat 13C urea breath test</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p>Carbon-13 urea breath testing is the only well validated method\nfor confirming the successful eradication of <em>Helicobacter\npylori.</em></p>\n\n<p>Re-testing for <em>Helicobacter pylori</em> is indicated only in\nthe setting of <a class=\"bp-link\" target=\"_blank\" href=\"https://bestpractice.bmj.com/topics/en-gb/80\">peptic ulcer disease</a> to confirm eradication where an\ninitial test is positive.</p>\n\n<p>Whilst stool antigen testing is appropriate in the setting of\ninitial diagnosis the NICE guidelines on dyspepsia do not recommend\nits use to confirm eradication due to a lack of evidence.</p>\n\n<p>Serological tests cannot be used to confirm eradication of\n<em>Helicobacter pylori</em> as they will not alter following\neradication, the performance of near-patient immunological tests is\nvariable at best and not recommended.</p>\n\n<p>Eradication therapy is effective in 80-85% of cases and should\nnot be repeated without evidence of treatment failure.</p>\n\n<div>Reference:</div>\n\n<p>NICE. <a href=\"http://www.nice.org.uk/guidance/CG184\" target=\"_blank\"><span class=\"\" data-bpid=\"82\">Gastro-oesophageal reflux disease</span> and dyspepsia in\nadults (CG184).</a></p></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>A 37-year-old man has been treated by his general practitioner\nfor dyspepsia.</p>\n\n<p>At endoscopy a duodenal ulcer was seen. He had a positive\n<em>H.pylori</em> <sup>13</sup>C urea breath test and has completed\na course of eradication therapy.</p>\n\n<p>According to the NICE guidelines on the management of\ngastro-oesophageal reflux disease and dyspepsia in adults, which of\nthe following is the most effective way of determining whether\neradication therapy has been successful?</p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"398259\" name=\"rdBtnOption+199820\" class=\"answer-radio\" value=\"398259\"><span>Repeat <sup>13</sup>C urea breath test</span></div><div class=\"option\"><input type=\"radio\" id=\"398257\" name=\"rdBtnOption+199820\" class=\"answer-radio\" value=\"398257\"><span class=\"textNotSelected\"><em>H. pylori</em> stool antigen test</span></div><div class=\"option\"><input type=\"radio\" id=\"398256\" name=\"rdBtnOption+199820\" class=\"answer-radio\" value=\"398256\"><span class=\"textNotSelected\">Formal laboratory <em>H. pylori</em> serology</span></div><div class=\"option\"><input type=\"radio\" id=\"398258\" name=\"rdBtnOption+199820\" class=\"answer-radio\" value=\"398258\"><span class=\"textNotSelected\">Near-patient testing for <em>H. pylori</em> antibodies</span></div><div class=\"option\"><input type=\"radio\" id=\"398260\" name=\"rdBtnOption+199820\" class=\"answer-radio\" value=\"398260\"><span class=\"textNotSelected\">Repeat eradication therapy with different antibiotics and\nmonitoring of response</span></div></div>",
        "id": 76
    },
    {
        "correctAnswerIndex": 1,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>Propranolol</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p><img src=\"asset/25.png\" width=\"355\" height=\"264\"></p>\n\n<p>The endoscopic picture demonstrates a number of dilated veins\nrunning through the oesophagus, these are varices (A). Propranolol\nis used in the primary prophylaxis of variceal haemorrhage and\nshould be commenced in this patient.</p>\n\n<p>Amoxicillin and clarithromycin are used for the eradication of\n<em>Helicobacter pylori</em> infection in the context of dyspepsia\nor peptic ulcer disease.</p>\n\n<p>Terlipressin is used in the management of acute variceal\nhaemorrhage.</p>\n\n<p>Tranexamic acid is not routinely used in the management of acute\nupper GI haemorrhage but may sometimes be used where there is\nchronic blood loss from an otherwise untreatable source (for\nexample, gastric cancer), it is not used in the management of\noesophageal varices.</p>\n\n<p>There is no indication for use of a proton pump inhibitor\nhere.</p></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>A 49-year-old man undergoes upper GI endoscopy for intermittent\ndysphagia. He has a history of alcohol excess and hepatitis C.</p>\n\n<p>A picture from the procedure demonstrating the only significant\nfinding is shown below:</p>\n\n<p><img src=\"asset/24.png\" width=\"467\" height=\"349\"></p>\n\n<p>What is the most appropriate treatment to commence\npost-endoscopy?</p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"398572\" name=\"rdBtnOption+199883\" class=\"answer-radio\" value=\"398572\"><span>Omeprazole</span></div><div class=\"option\"><input type=\"radio\" id=\"398573\" name=\"rdBtnOption+199883\" class=\"answer-radio\" value=\"398573\"><span>Propranolol</span></div><div class=\"option\"><input type=\"radio\" id=\"398575\" name=\"rdBtnOption+199883\" class=\"answer-radio\" value=\"398575\"><span class=\"textNotSelected\">Tranexamic acid</span></div><div class=\"option\"><input type=\"radio\" id=\"398571\" name=\"rdBtnOption+199883\" class=\"answer-radio\" value=\"398571\"><span class=\"textNotSelected\">Amoxicillin and clarithromycin</span></div><div class=\"option\"><input type=\"radio\" id=\"398574\" name=\"rdBtnOption+199883\" class=\"answer-radio\" value=\"398574\"><span class=\"textNotSelected\">Terlipressin</span></div></div>",
        "id": 77
    },
    {
        "correctAnswerIndex": 0,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>Caecal cancer</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p>This gentleman has a microcytic anaemia (suggesting iron\ndeficiency anaemia) with a significant change in bowel habit.\nAlthough melaena is typically associated with upper\ngastrointestinal bleeding right sided colonic lesions, particularly\nthose arising in the caecum, may give rise to melaena. In\ncombination with the systemic symptoms this makes a colonic\nmalignancy the most likely diagnosis.</p>\n\n<p>The black colour of the stool is caused by oxidation of the iron\nin haemoglobin during its passage through the ileum and colon.</p>\n\n<p>A colonic arteriovenous malformation would give rise to\nintermittent colonic bleeding (either fresh or altered) and could\nwell produce an <a class=\"bp-link\" target=\"_blank\" href=\"https://bestpractice.bmj.com/topics/en-gb/94\">iron deficiency anaemia</a>, however it would not be\nassociated with systemic features such as weight loss.</p>\n\n<p>Crohn's disease may present with anaemia, weight loss and a\nchange in bowel habit but is not usually associated with\ngastrointestinal bleeding, except in Crohn's colitis which is\nusually associated with fresh rectal bleeding.</p>\n\n<p>Diverticulosis gives rise to fresh rectal bleeding.</p>\n\n<p>Small bowel lymphomas typically present with abdominal pain,\nnausea, vomiting and features of intestinal obstruction; bleeding\nis not a common feature.</p></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>A 45-year-old man presents to the Emergency department with a\ntwo day history of passing dark, black stools.</p>\n\n<p>He describes 4 kilogram unintentional weight loss over the last\nsix months associated with alternating diarrhoea and\nconstipation.</p>\n\n<p>His blood tests show:</p>\n\n<table class=\"marginTop table table-bordered\">\n<tbody>\n<tr>\n<th>Haemoglobin</th>\n<td>62 g/L</td>\n<td>(130-180)</td>\n</tr>\n\n<tr>\n<th>White cell count</th>\n<td>12.3 \u00d710<sup>9</sup>/L</td>\n<td>(4-11)</td>\n</tr>\n\n<tr>\n<th>Platelets</th>\n<td>531 \u00d710<sup>9</sup>/L</td>\n<td>(150-400)</td>\n</tr>\n\n<tr>\n<th>MCV</th>\n<td>75 fL</td>\n<td>(80-96)</td>\n</tr>\n\n<tr>\n<th>C reactive protein</th>\n<td>&lt;5 mg/dL</td>\n<td>(&lt;10)</td>\n</tr>\n</tbody>\n</table>\n\n<p>An upper gastrointestinal endoscopy does not reveal any cause\nfor the bleeding.</p>\n\n<p>What is the most likely underlying diagnosis?</p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"398401\" name=\"rdBtnOption+199849\" class=\"answer-radio\" value=\"398401\"><span>Caecal cancer</span></div><div class=\"option\"><input type=\"radio\" id=\"398404\" name=\"rdBtnOption+199849\" class=\"answer-radio\" value=\"398404\"><span class=\"textNotSelected\">Diverticulosis</span></div><div class=\"option\"><input type=\"radio\" id=\"398402\" name=\"rdBtnOption+199849\" class=\"answer-radio\" value=\"398402\"><span class=\"textNotSelected\">Colonic arteriovenous malformation</span></div><div class=\"option\"><input type=\"radio\" id=\"398405\" name=\"rdBtnOption+199849\" class=\"answer-radio\" value=\"398405\"><span class=\"textNotSelected\">Small bowel lymphoma</span></div><div class=\"option\"><input type=\"radio\" id=\"398403\" name=\"rdBtnOption+199849\" class=\"answer-radio\" value=\"398403\"><span class=\"textNotSelected\">Crohn's disease</span></div></div>",
        "id": 78
    },
    {
        "correctAnswerIndex": 1,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>Repeat endoscopy with biopsies in 6 months</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p>An update to the full BSG guidance on management of\nBarrett's oesophagus was published in 2015 due to emerging\nevidence on the management of low-grade dysplasia in Barrett's\noesophagus. Data suggests that RFA of low-grade dysplasia is highly\neffective in preventing progression to high-grade dysplasia or\nearly oesophageal cancer. However the diagnosis of low-grade\ndysplasia is frequently over-estimated on histology and as such,\ncurrent recommendations are that low-grade dysplasia should only be\nconfirmed from two sets of biopsies evaluated by two pathologists,\none of whom should be a GI specialist pathologist and ideally\nshould involve external review.</p>\n\n<p>Therefore repeat endoscopy in 6 months is the current\nrecommended management followed by MDT review if dysplasia is\nconfirmed. Endoscopic mucosal resection is only appropriate for\nfocally suspicious lesions suggestive of high-grade dysplasia or T1\ncancer.</p>\n\n<p><strong>Reference:</strong></p>\n\n<p>Phoa, K.N., et al., Radiofrequency ablation vs endoscopic\nsurveillance for patients with Barrett esophagus and low-grade\ndysplasia: a randomized clinical trial. <em>JAMA</em>, 2014.\n311(12): p. 1209-17.</p>\n\n<p><a href=\"http://www.bsg.org.uk/images/stories/docs/clinical/guidelines/oesophageal/bsg_barretts_addendum_15.pdf \" target=\"_blank\">Tham T. Guidelines on the Diagnosis and Management\nof Barrett's Oesophagus&nbsp;</a></p></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>You scope a patient and find Barrett's oesophagus without\nany suspicious areas. Random sampling is reported as showing\nlow-grade dysplasia. You arrange clinic follow-up with the patient\nto discuss the implications of these findings.</p>\n\n<p>What course of action should you recommend to the patient?</p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"394606\" name=\"rdBtnOption+198987\" class=\"answer-radio\" value=\"394606\"><span>Recommend endoscopic mucosal resection of the Barrett's\nepithelium</span></div><div class=\"option\"><input type=\"radio\" id=\"394607\" name=\"rdBtnOption+198987\" class=\"answer-radio\" value=\"394607\"><span>Repeat endoscopy with biopsies in 6 months</span></div><div class=\"option\"><input type=\"radio\" id=\"394605\" name=\"rdBtnOption+198987\" class=\"answer-radio\" value=\"394605\"><span class=\"textNotSelected\">Recommend radio-frequency ablation (RFA) of the Barrett's\nepithelium</span></div><div class=\"option\"><input type=\"radio\" id=\"394608\" name=\"rdBtnOption+198987\" class=\"answer-radio\" value=\"394608\"><span class=\"textNotSelected\">Repeat endoscopy with biopsies in 1 year</span></div><div class=\"option\"><input type=\"radio\" id=\"394604\" name=\"rdBtnOption+198987\" class=\"answer-radio\" value=\"394604\"><span class=\"textNotSelected\">Refer to upper GI cancer MDT for consideration of oesophagectomy</span></div></div>",
        "id": 79
    },
    {
        "correctAnswerIndex": 2,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>Endoscopic mucosal resection (EMR) of the lesion</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p>Current guidelines recommend EMR as the procedure of choice for\nearly <a class=\"bp-link\" target=\"_blank\" href=\"https://bestpractice.bmj.com/topics/en-gb/1029\">oesophageal cancer</a> (T1 disease) or high-grade dysplasia.\nSurveillance or RFA are inferior and would not be recommended. If\nthere was extension into the sub-mucosa (staging usually performed\nby endoscopic ultrasound) then this would represent T2 disease and\noesophagogastrectomy would be recommended. EMR should be performed\nin high volume units with both endoscopic and surgical experience\navailable.</p>\n\n<p><strong>Reference:</strong></p>\n\n<p>Fitzgerald R et al. British Society of Gastroenterology\nguidelines on the diagnosis and management of Barrett's\noesophagus. Gut 2013;0:1-36. doi:10.1136.\n &nbsp;</p></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>You scope a patient with reflux and find Barrett's\noesophagus with a small, flat lesion at the GOJ. Biopsies of this\nlesion are reported as showing high-grade dysplasia with a\nsuspicion of invasive disease. The patient is fit. Repeat\nhigh-resolution endoscopy confirms your findings. Staging suggests\ndisease is within the mucosa with no submucosal extension.</p>\n\n<p>What would be the optimal management?</p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"394611\" name=\"rdBtnOption+198988\" class=\"answer-radio\" value=\"394611\"><span>Radio-frequency ablation (RFA) of the Barrett's epithelium</span></div><div class=\"option\"><input type=\"radio\" id=\"394612\" name=\"rdBtnOption+198988\" class=\"answer-radio\" value=\"394612\"><span class=\"textNotSelected\">Repeat endoscopy with biopsies in 6 months</span></div><div class=\"option\"><input type=\"radio\" id=\"394609\" name=\"rdBtnOption+198988\" class=\"answer-radio\" value=\"394609\"><span>Endoscopic mucosal resection (EMR) of the lesion</span></div><div class=\"option\"><input type=\"radio\" id=\"394613\" name=\"rdBtnOption+198988\" class=\"answer-radio\" value=\"394613\"><span class=\"textNotSelected\">Repeat endoscopy with biopsies in 1 year</span></div><div class=\"option\"><input type=\"radio\" id=\"394610\" name=\"rdBtnOption+198988\" class=\"answer-radio\" value=\"394610\"><span class=\"textNotSelected\">Oesophago-gastrectomy</span></div></div>",
        "id": 80
    },
    {
        "correctAnswerIndex": 0,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>Advanced dementia</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p>PEG feeding in dementia does not improve survival and it should\nonly be considered in very unusual circumstances. Stroke with\nunsafe swallow (14 days post stroke) and progressive neuromuscular\ndisease with unsafe swallow are common evidence-based indications\nfor PEG feeding.</p>\n\n<p><a class=\"bp-link\" target=\"_blank\" href=\"https://bestpractice.bmj.com/topics/en-gb/403\">Cystic fibrosis</a> patients often suffer nutritional failure that\ncan be ameliorated by PEG placement but this must be considered in\nconjunction with respiratory physicians.</p>\n\n<p>Irresectable oesophageal malignancy is an appropriate indication\nalthough stenting would be more common palliation.</p>\n\n<p>Gastric procedures should be avoided if surgical therapy is\nstill being considered.</p>\n\n<p><strong>Reference:</strong></p>\n\n<p>Westaby D. The provision of a percutaneously placed enteral tube\nfeeding service. <em>Gut</em> 2010;59:1592-1605.\n &nbsp;</p></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>You are screening referrals to the PEG tube service.</p>\n\n<p>Which of the following would NOT be an appropriate indication\nfor PEG tube feeding?</p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"394614\" name=\"rdBtnOption+198989\" class=\"answer-radio\" value=\"394614\"><span>Advanced dementia</span></div><div class=\"option\"><input type=\"radio\" id=\"394617\" name=\"rdBtnOption+198989\" class=\"answer-radio\" value=\"394617\"><span class=\"textNotSelected\">Irresectable obstructing oesophageal malignancy</span></div><div class=\"option\"><input type=\"radio\" id=\"394615\" name=\"rdBtnOption+198989\" class=\"answer-radio\" value=\"394615\"><span class=\"textNotSelected\">Cystic fibrosis</span></div><div class=\"option\"><input type=\"radio\" id=\"394618\" name=\"rdBtnOption+198989\" class=\"answer-radio\" value=\"394618\"><span class=\"textNotSelected\">Stroke with unsafe swallow</span></div><div class=\"option\"><input type=\"radio\" id=\"394616\" name=\"rdBtnOption+198989\" class=\"answer-radio\" value=\"394616\"><span class=\"textNotSelected\">Huntingdon's disease with loss of safe swallow</span></div></div>",
        "id": 81
    },
    {
        "correctAnswerIndex": 4,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>Post-polypectomy perforation rate <1 in 500</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n    <div class=\"alert alert-warning fontsize14 w-100\">\n        <span class=\"fontsize18\">Key Learning Points</span>\n        \n\n        \n\n\n\n        <p>Endoscopy</p>\n\n        <ul>\n                <li>Overall colonoscopy perforation rate should be &lt; 1 in 1000 and good quality bowel preparation should be recorded in &gt;90% of cases.</li>\n        </ul>\n        \n        \n\n        <div>\n            <label id=\"KLPSuccessMsg\" style=\"display:none\" class=\"text-success fontsize14\">Your preference has been recorded successfully.</label>\n        </div>\n    </div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p>The colonoscopy completion rate should be unadjusted and\n&gt;90%.</p>\n\n<p>Overall colonoscopy perforation rate should be &lt; 1 in 1000\nand good quality bowel preparation should be recorded in &gt;90% of\ncases.</p>\n\n<p>Polyp recovery rate should be &gt;90% according to BSG/JAG\nguidance.</p>\n\n<p><strong>References:</strong></p>\n\n<p><a href=\"https://www.thejag.org.uk/Downloads/Accreditation/Guidance%20-%20BSG%20Quality%20and%20Safety%20Indicators.pdf\" target=\"_blank\">BSG Quality and Safety Indicators for\nendoscopy.&nbsp;</a></p></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>You are performing an endoscopy unit audit of local lower GI\nendoscopy practice.</p>\n\n<p>Which of these is the correct standard that units or networks\nshould achieve according to BSG/JAG guidance?</p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"394550\" name=\"rdBtnOption+198976\" class=\"answer-radio\" value=\"394550\"><span>Colonoscopy perforation rate &lt;1 in 500</span></div><div class=\"option\"><input type=\"radio\" id=\"394551\" name=\"rdBtnOption+198976\" class=\"answer-radio\" value=\"394551\"><span class=\"textNotSelected\">Good quality bowel preparation in &gt;75% cases</span></div><div class=\"option\"><input type=\"radio\" id=\"394549\" name=\"rdBtnOption+198976\" class=\"answer-radio\" value=\"394549\"><span class=\"textNotSelected\">&gt;90% adjusted completion rate for colonoscopy</span></div><div class=\"option\"><input type=\"radio\" id=\"394552\" name=\"rdBtnOption+198976\" class=\"answer-radio\" value=\"394552\"><span class=\"textNotSelected\">Polyp recovery rate &gt;95%</span></div><div class=\"option\"><input type=\"radio\" id=\"394553\" name=\"rdBtnOption+198976\" class=\"answer-radio\" value=\"394553\"><span>Post-polypectomy perforation rate &lt;1 in 500</span></div></div>",
        "id": 82
    },
    {
        "correctAnswerIndex": 3,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>Tubulo-villous adenoma</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p>This question refers to the Kudo classification of pit pattern\nwhich can be used to provide 'optical biopsy' of lesions in the\ncolon, although clearly not a substitute for definitive histology.\nA pattern similar to brain gyri is most suggestive of a\ntubulo-villous adenoma. Hyper plastic polyps are associated with\nasteroid pit patterns, tubular adenomas with enlargement or\nshrinking of a relatively normal appearing pit pattern and invasive\ncancer with a total pattern loss.</p>\n\n<p>In such a case 'optical biopsy' may be useful. If cancer is not\nsuspected after detailed interrogation of the polyp, a reasonable\ncourse of action may be to tattoo and refer to a colleague for EMR.\nAvoiding biopsy will prevent scarring and possible difficulty in\nlifting the polyp at future EMR. However, if cancer is suspected\ndue to pit pattern, then biopsy is indicated to expedite diagnosis\nand treatment. In this case, biopsies can be targeted at the most\nabnormal mucosa.</p>\n\n<p><strong>Reference:</strong></p>\n\n<p>Kudo S, Tamura S, Nakajima T, Yamano H, Kusaka H, Wa- tanabe H.\nDiagnosis of colorectal tumorous lesions by magnifying endoscopy.\n<em>Gastrointest Endosc</em> 1996; 44: 8-14.</p></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>You perform a colonoscopy where you detect a 35 mm sigmoid\npolyp. You examine the pit pattern in detail and find the pits to\nhave a dendritic appearance similar to brain gyri patterns. The\npolyp is resected and sent for histology.</p>\n\n<p>What would you expect the final histology to confirm?</p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"394537\" name=\"rdBtnOption+198973\" class=\"answer-radio\" value=\"394537\"><span>Tubular adenoma</span></div><div class=\"option\"><input type=\"radio\" id=\"394534\" name=\"rdBtnOption+198973\" class=\"answer-radio\" value=\"394534\"><span class=\"textNotSelected\">Hyperplastic polyp</span></div><div class=\"option\"><input type=\"radio\" id=\"394535\" name=\"rdBtnOption+198973\" class=\"answer-radio\" value=\"394535\"><span class=\"textNotSelected\">Inflammatory polyp</span></div><div class=\"option\"><input type=\"radio\" id=\"394538\" name=\"rdBtnOption+198973\" class=\"answer-radio\" value=\"394538\"><span>Tubulo-villous adenoma</span></div><div class=\"option\"><input type=\"radio\" id=\"394536\" name=\"rdBtnOption+198973\" class=\"answer-radio\" value=\"394536\"><span class=\"textNotSelected\">Invasive adenocarcinoma</span></div></div>",
        "id": 83
    },
    {
        "correctAnswerIndex": 0,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>13-15 mm</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p>Current BSG guidance recommends that benign peptic strictures\nare dilated to 13-15 mm as most will respond symptomatically at\nthat diameter. If symptoms persist progressively larger diameter\ndilatations can be attempted.</p>\n\n<p>Reference:</p>\n\n<p>S A Riley, S E A Attwood. Guidelines on the use of oesophageal\ndilatation in clinical practice. <em>Gut</em> 2004;53(Suppl\nI):i1-i6</p></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>You are performing an oesophageal dilatation for a symptomatic,\nbenign peptic stricture in the lower third of the oesophagus.</p>\n\n<p>What diameter would you aim to dilate to give a good symptomatic\nresult?</p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"394596\" name=\"rdBtnOption+198985\" class=\"answer-radio\" value=\"394596\"><span>13-15 mm</span></div><div class=\"option\"><input type=\"radio\" id=\"394598\" name=\"rdBtnOption+198985\" class=\"answer-radio\" value=\"394598\"><span class=\"textNotSelected\">30-40 mm</span></div><div class=\"option\"><input type=\"radio\" id=\"394594\" name=\"rdBtnOption+198985\" class=\"answer-radio\" value=\"394594\"><span class=\"textNotSelected\">8-10 mm</span></div><div class=\"option\"><input type=\"radio\" id=\"394597\" name=\"rdBtnOption+198985\" class=\"answer-radio\" value=\"394597\"><span class=\"textNotSelected\">16-20 mm</span></div><div class=\"option\"><input type=\"radio\" id=\"394595\" name=\"rdBtnOption+198985\" class=\"answer-radio\" value=\"394595\"><span class=\"textNotSelected\">10-12 mm</span></div></div>",
        "id": 84
    },
    {
        "correctAnswerIndex": 2,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>She requires a blood test for Helicobacter pylori infection</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p>This lady has a clinical history and blood test evidence\n(reactive thrombocytosis and urea elevated in excess of creatinine)\nof upper gastrointestinal haemorrhage.</p>\n\n<p>Upper gastrointestinal endoscopy reveals multiple peptic\nulcerations as the likely source of bleeding. Multiple duodenal\nulcers are suggestive of <em>Helicobacter pylori</em> infection, as\nis the history of relapsing and remitting dyspeptic symptoms.\nAlthough the rapid urease (for example, CLO) test is negative this\ndoes not exclude <em>Helicobacter pylori</em> infection. Although\nrapid urease testing has a sensitivity of 93-97% the false negative\nrate increases significantly in the context of recent\ngastrointestinal haemorrhage, acid suppression therapy and recent\nantibiotic treatment. Serological markers would indicate the\nlikelihood of <em>Helicobacter pylori</em> infection and are\nunaffected by the factors mentioned above.</p>\n\n<p>Increases in the false negative rate of rapid urease testing\nwith upper gastrointestinal bleeding and acid suppression therapy\nmean that this lady cannot be considered to have been proven not to\nhave <em>Helicobacter pylori</em> infection, especially with such a\nsuggestive clinical presentation.</p>\n\n<p>There is no evidence to suggest that empirical <em>Helicobacter\npylori</em> eradication therapy (that is, in the absence of\nfeatures suggestive of infection) improves outcome in this\nsetting.</p>\n\n<p>Faecal antigen testing for <em>Helicobacter pylori</em> is also\nmade significantly less sensitive by concurrent acid suppression\ntherapy which this lady will now need to take for at least eight\nweeks.</p>\n\n<p>This lady has had complicated <a class=\"bp-link\" target=\"_blank\" href=\"https://bestpractice.bmj.com/topics/en-gb/80\">peptic ulcer disease</a> (that is,\nulcer disease with gastrointestinal haemorrhage), <em>Helicobacter\npylori</em> eradication therapy significantly increases healing\nrates and reduces recurrence.</p>\n\n<p>Delaying further testing until ulcer healing is determined at an\neight week endoscopy (indicated due to the presence of a gastric\nulcer) is inappropriate; there is also no guarantee that acid\nsuppression treatment could be discontinued at this time.</p></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>A 58-year-old lady is admitted to hospital with a history of\npassing dark black stools.</p>\n\n<p>She describes a history of intermittent epigastric discomfort\nand indigestion for which she has been self-medicating with\nGaviscon and ranitidine over the counter. She has no past medical\nhistory.</p>\n\n<p>Her blood tests show:</p>\n\n<table class=\"marginTop table table-bordered\">\n<tbody>\n<tr>\n<th>Haemoglobin</th>\n<td>102 g/L</td>\n<td>(130 - 180)</td>\n</tr>\n\n<tr>\n<th>White cell count</th>\n<td>7.9 \u00d710<sup>9</sup>/L</td>\n<td>(4 - 11)</td>\n</tr>\n\n<tr>\n<th>Platelets</th>\n<td>512 \u00d710<sup>9</sup>/L</td>\n<td>(150 - 400)</td>\n</tr>\n\n<tr>\n<th>Sodium</th>\n<td>135 mmol/L</td>\n<td>(137 - 144)</td>\n</tr>\n\n<tr>\n<th>Potassium</th>\n<td>3.2 mmol/L</td>\n<td>(3.5 - 4.9)</td>\n</tr>\n\n<tr>\n<th>Urea</th>\n<td>10.9 mmol/L</td>\n<td>(2.5 - 7.5)</td>\n</tr>\n\n<tr>\n<th>Creatinine</th>\n<td>78 \u00b5mol/L</td>\n<td>(60 - 110)</td>\n</tr>\n</tbody>\n</table>\n\n<p>Upper gastrointestinal endoscopy reveals a single gastric ulcer\nand several duodenal ulcers. A rapid urease test performed at\nendoscopy is negative.</p>\n\n<p>She has received a leaflet about <em>Helicobacter pylori</em>\nand asks you about her treatment for this infection.</p>\n\n<p>What is the most appropriate advice to give her based upon her\ntest results?</p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"398196\" name=\"rdBtnOption+199808\" class=\"answer-radio\" value=\"398196\"><span>If her ulcers do not heal with eight weeks of proton pump inhibitor\ntreatment she should receive <em>Helicobacterpylori</em>eradication\ntherapy</span></div><div class=\"option\"><input type=\"radio\" id=\"398200\" name=\"rdBtnOption+199808\" class=\"answer-radio\" value=\"398200\"><span class=\"textNotSelected\">She should receive <em>Helicobacter pylori</em> eradication therapy</span></div><div class=\"option\"><input type=\"radio\" id=\"398198\" name=\"rdBtnOption+199808\" class=\"answer-radio\" value=\"398198\"><span>She requires a blood test for <em>Helicobacter pylori</em>\ninfection</span></div><div class=\"option\"><input type=\"radio\" id=\"398199\" name=\"rdBtnOption+199808\" class=\"answer-radio\" value=\"398199\"><span class=\"textNotSelected\">She requires a stool test for <em>Helicobacter pylori</em>\ninfection</span></div><div class=\"option\"><input type=\"radio\" id=\"398197\" name=\"rdBtnOption+199808\" class=\"answer-radio\" value=\"398197\"><span class=\"textNotSelected\">She has been proven not to have <em>Helicobacter pylori</em>\ninfection</span></div></div>",
        "id": 85
    },
    {
        "correctAnswerIndex": 3,
        "exp": "\n                                <div class='correct-answer-div'>\n                                    <span class='text'>Correct answer : </span>\n                                    <span>16-20 mm</span>\n                                </div>\n                            \n    \n\n    <div>\n                \n    </div>\n\n    \n\n    <div id=\"errorDiv\" class=\"errorMessage fontsize14 p-2\" style=\"display:none\"></div>\n\n<div>\n</div>            <span class=\"fontsize18\">Explanation</span>\n            <div class=\"answerExplanation\"><p>Current BSG guidance recommends that Schatzki's rings are\ndilated to 16-20 mm a slightly larger diameter than benign peptic\nstrictures.</p>\n\n<p>Dilatation for <a class=\"bp-link\" target=\"_blank\" href=\"https://bestpractice.bmj.com/topics/en-gb/872\">achalasia</a> aims to disrupt the lower oesophageal\nsphincter and so larger diameter dilators (30-40 mm) are often\nused. When dilating malignant strictures the lowest diameter to\nachieve the clinical intention (biopsies, stent placement etc.) is\nrecommended due to increased risk of perforation.</p>\n\n<p><strong>Reference:</strong></p>\n\n<p>S A Riley, S E A Attwood. Guidelines on the use of oesophageal\ndilatation in clinical practice. <em>Gut</em> 2004;53(Suppl\nI):i1-i6</p></div>\n        \n",
        "question": "<div class=\"questionWrapper\"><p>You are performing an oesophageal dilatation for a Schatzki ring\nin the lower third of the oesophagus.&nbsp;</p>\n\n<p>What diameter would you aim to dilate to give a good symptomatic\nresult?</p></div><div class=\"questionOptions options\"><div class=\"option\"><input type=\"radio\" id=\"394599\" name=\"rdBtnOption+198986\" class=\"answer-radio\" value=\"394599\"><span>8-10 mm</span></div><div class=\"option\"><input type=\"radio\" id=\"394601\" name=\"rdBtnOption+198986\" class=\"answer-radio\" value=\"394601\"><span class=\"textNotSelected\">13-15 mm</span></div><div class=\"option\"><input type=\"radio\" id=\"394603\" name=\"rdBtnOption+198986\" class=\"answer-radio\" value=\"394603\"><span class=\"textNotSelected\">30-40 mm</span></div><div class=\"option\"><input type=\"radio\" id=\"394602\" name=\"rdBtnOption+198986\" class=\"answer-radio\" value=\"394602\"><span>16-20 mm</span></div><div class=\"option\"><input type=\"radio\" id=\"394600\" name=\"rdBtnOption+198986\" class=\"answer-radio\" value=\"394600\"><span class=\"textNotSelected\">10-12 mm</span></div></div>",
        "id": 86
    }
]